{
    "5e2b109cfbd6abf43b000002": [
        {
            "text": "Length of stay",
            "probability": 0.1519667090219284,
            "start_logit": 5.354716777801514,
            "end_logit": 5.119957447052002,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Length of stay, Acuity of admission",
            "probability": 0.14605829047244456,
            "start_logit": 5.354716777801514,
            "end_logit": 5.080301761627197,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Length of stay, Acuity of admission, Co-morbidities and Emergency department visits",
            "probability": 0.14596944918094493,
            "start_logit": 5.354716777801514,
            "end_logit": 5.07969331741333,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Length of stay, Acuity of admission, Co-morbidities",
            "probability": 0.11666507796642839,
            "start_logit": 5.354716777801514,
            "end_logit": 4.855603218078613,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Co-morbidities and Emergency department visits",
            "probability": 0.0784144293762985,
            "start_logit": 4.733327388763428,
            "end_logit": 5.07969331741333,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Acuity of admission",
            "probability": 0.07225295064225647,
            "start_logit": 4.65088415145874,
            "end_logit": 5.080301761627197,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Acuity of admission, Co-morbidities and Emergency department visits",
            "probability": 0.07220900212397002,
            "start_logit": 4.65088415145874,
            "end_logit": 5.07969331741333,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Emergency department visits",
            "probability": 0.06753972656106284,
            "start_logit": 4.584035396575928,
            "end_logit": 5.07969331741333,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Co-morbidities",
            "probability": 0.06267219317611207,
            "start_logit": 4.733327388763428,
            "end_logit": 4.855603218078613,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Acuity of admission, Co-morbidities",
            "probability": 0.057712548138947634,
            "start_logit": 4.65088415145874,
            "end_logit": 4.855603218078613,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Length of stay, Acuity",
            "probability": 0.014560368389853164,
            "start_logit": 5.354716777801514,
            "end_logit": 2.774599313735962,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Acuity",
            "probability": 0.007202806326174333,
            "start_logit": 4.65088415145874,
            "end_logit": 2.774599313735962,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Length",
            "probability": 0.002020804669854734,
            "start_logit": 5.354716777801514,
            "end_logit": 0.7997917532920837,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Length of stay, Acuity of admission,",
            "probability": 0.000895195088226196,
            "start_logit": 5.354716777801514,
            "end_logit": -0.014417639002203941,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Length of stay, Acuity of admission, Co",
            "probability": 0.0007869798620319522,
            "start_logit": 5.354716777801514,
            "end_logit": -0.14325664937496185,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Length of stay,",
            "probability": 0.0006950149790096185,
            "start_logit": 5.354716777801514,
            "end_logit": -0.26752591133117676,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "admission",
            "probability": 0.0006917480074669092,
            "start_logit": 0.0021774452179670334,
            "end_logit": 5.080301761627197,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "admission, Co-morbidities and Emergency department visits",
            "probability": 0.0006913272454124112,
            "start_logit": 0.0021774452179670334,
            "end_logit": 5.07969331741333,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "admission, Co-morbidities",
            "probability": 0.0005525385444619721,
            "start_logit": 0.0021774452179670334,
            "end_logit": 4.855603218078613,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Acuity of admission,",
            "probability": 0.0004428402271146698,
            "start_logit": 4.65088415145874,
            "end_logit": -0.014417639002203941,
            "question_text": "What is included in the LACE Index?"
        }
    ],
    "5e2f906ffbd6abf43b00002c": [
        {
            "text": "CBD",
            "probability": 0.7955160689284456,
            "start_logit": 2.423705577850342,
            "end_logit": 0.9556149244308472,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "CBD.",
            "probability": 0.19310375582729075,
            "start_logit": 2.423705577850342,
            "end_logit": -0.46014848351478577,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "C",
            "probability": 0.0059098741004092676,
            "start_logit": 2.423705577850342,
            "end_logit": -3.946751594543457,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "CB",
            "probability": 0.0014168332611784584,
            "start_logit": 2.423705577850342,
            "end_logit": -5.3749518394470215,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "poorly soluble drugs in-vivo, specifically assessing absorption kinetics of CBD",
            "probability": 0.0008945792094425293,
            "start_logit": -4.366687297821045,
            "end_logit": 0.9556149244308472,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "drugs in-vivo, specifically assessing absorption kinetics of CBD",
            "probability": 0.0005893981100632064,
            "start_logit": -4.783938884735107,
            "end_logit": 0.9556149244308472,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "absorption kinetics of CBD",
            "probability": 0.0005697669126589186,
            "start_logit": -4.817813396453857,
            "end_logit": 0.9556149244308472,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "D",
            "probability": 0.0003945239467567418,
            "start_logit": -5.185360908508301,
            "end_logit": 0.9556149244308472,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "specifically assessing absorption kinetics of CBD",
            "probability": 0.00024027531408875403,
            "start_logit": -5.681255340576172,
            "end_logit": 0.9556149244308472,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": ", specifically assessing absorption kinetics of CBD",
            "probability": 0.00023017075034386284,
            "start_logit": -5.72421932220459,
            "end_logit": 0.9556149244308472,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "poorly soluble drugs in-vivo, specifically assessing absorption kinetics of CBD.",
            "probability": 0.0002171503656249828,
            "start_logit": -4.366687297821045,
            "end_logit": -0.46014848351478577,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "assessing absorption kinetics of CBD",
            "probability": 0.0002010588318043949,
            "start_logit": -5.859443187713623,
            "end_logit": 0.9556149244308472,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "drugs in-vivo, specifically assessing absorption kinetics of CBD.",
            "probability": 0.00014307063449267593,
            "start_logit": -4.783938884735107,
            "end_logit": -0.46014848351478577,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "absorption kinetics of CBD.",
            "probability": 0.00013830535306314908,
            "start_logit": -4.817813396453857,
            "end_logit": -0.46014848351478577,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": ".",
            "probability": 0.00012005089613877102,
            "start_logit": -4.959361553192139,
            "end_logit": -0.46014848351478577,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "D.",
            "probability": 9.576683471039408e-05,
            "start_logit": -5.185360908508301,
            "end_logit": -0.46014848351478577,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "specifically assessing absorption kinetics of CBD.",
            "probability": 5.8324485695956096e-05,
            "start_logit": -5.681255340576172,
            "end_logit": -0.46014848351478577,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "lipophilic drugs.This method was used to shed light on the complex absorption process of poorly soluble drugs in-vivo,",
            "probability": 5.634946859839648e-05,
            "start_logit": -3.0384154319763184,
            "end_logit": -3.137437582015991,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": ", specifically assessing absorption kinetics of CBD.",
            "probability": 5.5871701539423525e-05,
            "start_logit": -5.72421932220459,
            "end_logit": -0.46014848351478577,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "assessing absorption kinetics of CBD.",
            "probability": 4.880506765372254e-05,
            "start_logit": -5.859443187713623,
            "end_logit": -0.46014848351478577,
            "question_text": "Which drugs are included in GI cocktail?"
        }
    ],
    "5e48136dd14c9f295d000008": [
        {
            "text": "129S2/SvHsd cells",
            "probability": 0.29756906512553344,
            "start_logit": 1.1142524480819702,
            "end_logit": -0.3630402684211731,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "129S2/SvHsd",
            "probability": 0.26073597520890623,
            "start_logit": 1.1142524480819702,
            "end_logit": -0.49517831206321716,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "129S2",
            "probability": 0.17108087520108625,
            "start_logit": 1.1142524480819702,
            "end_logit": -0.9165502190589905,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "Mitomycin C and alpha particles induced lower levels of sister chromatid exchanges in 129S2/SvHsd cells",
            "probability": 0.04048256599178864,
            "start_logit": -0.8805224895477295,
            "end_logit": -0.3630402684211731,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "Mitomycin C and alpha particles induced lower levels of sister chromatid exchanges in 129S2/SvHsd",
            "probability": 0.035471635192909044,
            "start_logit": -0.8805224895477295,
            "end_logit": -0.49517831206321716,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "129S2/SvHsd cells compared to CBA/H and C57BL/6.",
            "probability": 0.02453744805432948,
            "start_logit": 1.1142524480819702,
            "end_logit": -2.8584861755371094,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "Mitomycin C and alpha particles induced lower levels of sister chromatid exchanges in 129S2",
            "probability": 0.02327457263522737,
            "start_logit": -0.8805224895477295,
            "end_logit": -0.9165502190589905,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "sister chromatid exchanges in 129S2/SvHsd cells",
            "probability": 0.01985543494919495,
            "start_logit": -1.5929161310195923,
            "end_logit": -0.3630402684211731,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "129S2/SvHsd cells compared to CBA/H and C57BL/6",
            "probability": 0.018579205473258274,
            "start_logit": 1.1142524480819702,
            "end_logit": -3.136643648147583,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "sister chromatid exchanges in 129S2/SvHsd",
            "probability": 0.01739772980935148,
            "start_logit": -1.5929161310195923,
            "end_logit": -0.49517831206321716,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "Mitomycin C and alpha particles induced lower levels of sister chromatid exchanges",
            "probability": 0.011584631845210537,
            "start_logit": -0.8805224895477295,
            "end_logit": -1.6142323017120361,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "sister chromatid exchanges in 129S2",
            "probability": 0.01141545135806871,
            "start_logit": -1.5929161310195923,
            "end_logit": -0.9165502190589905,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "Mitomycin C",
            "probability": 0.010976261663525931,
            "start_logit": -0.8805224895477295,
            "end_logit": -1.6681767702102661,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "129S2/SvHsd cells compared",
            "probability": 0.010161911399094344,
            "start_logit": 1.1142524480819702,
            "end_logit": -3.7400400638580322,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "129",
            "probability": 0.010133456896258511,
            "start_logit": 1.1142524480819702,
            "end_logit": -3.7428441047668457,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "cells",
            "probability": 0.009853650343683806,
            "start_logit": -2.2935519218444824,
            "end_logit": -0.3630402684211731,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "in 129S2/SvHsd cells",
            "probability": 0.007885209551684784,
            "start_logit": -2.5164051055908203,
            "end_logit": -0.3630402684211731,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "in 129S2/SvHsd",
            "probability": 0.0069091785509282745,
            "start_logit": -2.5164051055908203,
            "end_logit": -0.49517831206321716,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "SvHsd cells",
            "probability": 0.006413840446021576,
            "start_logit": -2.722935676574707,
            "end_logit": -0.3630402684211731,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "sister chromatid exchanges",
            "probability": 0.005681900303938395,
            "start_logit": -1.5929161310195923,
            "end_logit": -1.6142323017120361,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        }
    ],
    "5e482160d14c9f295d00000c": [
        {
            "text": "antioxidant activity",
            "probability": 0.17687885277827464,
            "start_logit": -2.7237207889556885,
            "end_logit": -2.8121819496154785,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "effect of different enzymatic treatments on antioxidant activity",
            "probability": 0.10056547736672343,
            "start_logit": -3.288376808166504,
            "end_logit": -2.8121819496154785,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "activity",
            "probability": 0.0794311800011842,
            "start_logit": -3.524294853210449,
            "end_logit": -2.8121819496154785,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "antioxidants. In this study, the effect of different enzymatic treatments on antioxidant activity",
            "probability": 0.06951882617627347,
            "start_logit": -3.657588243484497,
            "end_logit": -2.8121819496154785,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "study, the effect of different enzymatic treatments on antioxidant activity",
            "probability": 0.06775409275635427,
            "start_logit": -3.6833009719848633,
            "end_logit": -2.8121819496154785,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "In this study, the effect of different enzymatic treatments on antioxidant activity",
            "probability": 0.05648643827645618,
            "start_logit": -3.865185260772705,
            "end_logit": -2.8121819496154785,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": ", the effect of different enzymatic treatments on antioxidant activity",
            "probability": 0.04637518535250242,
            "start_logit": -4.0624213218688965,
            "end_logit": -2.8121819496154785,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "antioxidant",
            "probability": 0.0440717083982831,
            "start_logit": -2.7237207889556885,
            "end_logit": -4.201828956604004,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "antioxidants. In this study,",
            "probability": 0.04040730373990701,
            "start_logit": -3.657588243484497,
            "end_logit": -3.354768991470337,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "study,",
            "probability": 0.039381565486821,
            "start_logit": -3.6833009719848633,
            "end_logit": -3.354768991470337,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "the effect of different enzymatic treatments on antioxidant activity",
            "probability": 0.03590321843389467,
            "start_logit": -4.318358898162842,
            "end_logit": -2.8121819496154785,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "In this study,",
            "probability": 0.03283232462577555,
            "start_logit": -3.865185260772705,
            "end_logit": -3.354768991470337,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "enzymatic treatments on antioxidant activity",
            "probability": 0.031887943876735894,
            "start_logit": -4.436957836151123,
            "end_logit": -2.8121819496154785,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "antioxidants. In this study",
            "probability": 0.028190691198492192,
            "start_logit": -3.657588243484497,
            "end_logit": -3.714787721633911,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "study",
            "probability": 0.02747507130637179,
            "start_logit": -3.6833009719848633,
            "end_logit": -3.714787721633911,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": ",",
            "probability": 0.02695523361947394,
            "start_logit": -4.0624213218688965,
            "end_logit": -3.354768991470337,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "this study, the effect of different enzymatic treatments on antioxidant activity",
            "probability": 0.025452117588800453,
            "start_logit": -4.662386894226074,
            "end_logit": -2.8121819496154785,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "effect of different enzymatic treatments on antioxidant",
            "probability": 0.02505722037329242,
            "start_logit": -3.288376808166504,
            "end_logit": -4.201828956604004,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "In this study",
            "probability": 0.022905906585887422,
            "start_logit": -3.865185260772705,
            "end_logit": -3.714787721633911,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "effect of different enzymatic treatments",
            "probability": 0.022469642058495824,
            "start_logit": -3.288376808166504,
            "end_logit": -4.310825824737549,
            "question_text": "List five proteins with antioxidant properties?"
        }
    ],
    "5c72c9207c78d6947100007b": [
        {
            "text": "microarray image analysis in a study of a metabolic disorder in yeast, where replicates of reporters are present.Improved microarray spot segmentation",
            "probability": 0.11999462066517039,
            "start_logit": -2.59230375289917,
            "end_logit": -3.504296064376831,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "automatic",
            "probability": 0.09594306798052174,
            "start_logit": -3.475459575653076,
            "end_logit": -2.844832181930542,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "microarray spot segmentation",
            "probability": 0.08096279593279421,
            "start_logit": -2.9857609272003174,
            "end_logit": -3.504296064376831,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "fully automatic",
            "probability": 0.08046037836262766,
            "start_logit": -3.651449680328369,
            "end_logit": -2.844832181930542,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "a fully automatic",
            "probability": 0.061068451873556466,
            "start_logit": -3.9272191524505615,
            "end_logit": -2.844832181930542,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "microarray image analysis",
            "probability": 0.05539880455758706,
            "start_logit": -2.59230375289917,
            "end_logit": -4.277184963226318,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "segmentation methods",
            "probability": 0.051236202721222666,
            "start_logit": -3.8943443298339844,
            "end_logit": -3.053256034851074,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "segmentation method",
            "probability": 0.04536231556357937,
            "start_logit": -3.425391674041748,
            "end_logit": -3.6439733505249023,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "automatic segmentation method",
            "probability": 0.04314703947458928,
            "start_logit": -3.475459575653076,
            "end_logit": -3.6439733505249023,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "microarray",
            "probability": 0.04307710308736767,
            "start_logit": -2.59230375289917,
            "end_logit": -4.528751373291016,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "segmentation",
            "probability": 0.04032287406775234,
            "start_logit": -3.425391674041748,
            "end_logit": -3.7617361545562744,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "microarray image analysis in a study of a metabolic disorder in yeast, where replicates of reporters are present.Improved microarray spot",
            "probability": 0.03992780429085289,
            "start_logit": -2.59230375289917,
            "end_logit": -4.60467004776001,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "automatic segmentation",
            "probability": 0.038353699927238034,
            "start_logit": -3.475459575653076,
            "end_logit": -3.7617361545562744,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "fully automatic segmentation method",
            "probability": 0.03618424128419045,
            "start_logit": -3.651449680328369,
            "end_logit": -3.6439733505249023,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "fully automatic segmentation",
            "probability": 0.032164420762308375,
            "start_logit": -3.651449680328369,
            "end_logit": -3.7617361545562744,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "segmentation method for improving the spot segmentation result.Our method is compared to widely used, state-of-the-art segmentation methods",
            "probability": 0.028676646850872987,
            "start_logit": -3.425391674041748,
            "end_logit": -4.102571964263916,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "a fully automatic segmentation method",
            "probability": 0.02746340052598001,
            "start_logit": -3.9272191524505615,
            "end_logit": -3.6439733505249023,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "automatic segmentation method for improving the spot segmentation result.Our method is compared to widely used, state-of-the-art segmentation methods",
            "probability": 0.027276218118523255,
            "start_logit": -3.475459575653076,
            "end_logit": -4.102571964263916,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "microarray spot",
            "probability": 0.026940096588706334,
            "start_logit": -2.9857609272003174,
            "end_logit": -4.60467004776001,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "microarray spot segmentation by combining two information channels",
            "probability": 0.026039817364558845,
            "start_logit": -2.9857609272003174,
            "end_logit": -4.6386590003967285,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        }
    ],
    "5e369ecfb5b409ea53000002": [
        {
            "text": "Transcribed ultraconserved regions",
            "probability": 0.638526820196974,
            "start_logit": -2.787400484085083,
            "end_logit": -2.3022878170013428,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "ultraconserved regions",
            "probability": 0.0638022943123337,
            "start_logit": -5.090775012969971,
            "end_logit": -2.3022878170013428,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "Transcribed ultraconserved",
            "probability": 0.03914830866781023,
            "start_logit": -2.787400484085083,
            "end_logit": -5.094094276428223,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "565 regions",
            "probability": 0.03475411199862753,
            "start_logit": -3.308854579925537,
            "end_logit": -4.691699504852295,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "565",
            "probability": 0.03397792582734786,
            "start_logit": -3.308854579925537,
            "end_logit": -4.7142863273620605,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "single nucleotide polymorphisms",
            "probability": 0.03199418767646661,
            "start_logit": -4.065576553344727,
            "end_logit": -4.017721176147461,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "565 regions of lncRNAs",
            "probability": 0.023407291478504542,
            "start_logit": -3.308854579925537,
            "end_logit": -5.086949825286865,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "We selected 565 regions",
            "probability": 0.014377441203870219,
            "start_logit": -4.191492080688477,
            "end_logit": -4.691699504852295,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "We selected 565",
            "probability": 0.014056340465020342,
            "start_logit": -4.191492080688477,
            "end_logit": -4.7142863273620605,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "single nucleotide polymorphism",
            "probability": 0.012575976448829792,
            "start_logit": -4.065576553344727,
            "end_logit": -4.951487064361572,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "single nucleotide polymorphisms (SNPs) in these regions with breast cancer risk",
            "probability": 0.011279183567543018,
            "start_logit": -4.065576553344727,
            "end_logit": -5.060316562652588,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "single nucleotide polymorphisms (SNPs) in these regions with breast cancer",
            "probability": 0.011147936570084607,
            "start_logit": -4.065576553344727,
            "end_logit": -5.072021007537842,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "selected 565 regions",
            "probability": 0.010430843179340007,
            "start_logit": -4.512385368347168,
            "end_logit": -4.691699504852295,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "selected 565",
            "probability": 0.010197884379215571,
            "start_logit": -4.512385368347168,
            "end_logit": -4.7142863273620605,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "We selected 565 regions of lncRNAs",
            "probability": 0.00968337090550153,
            "start_logit": -4.191492080688477,
            "end_logit": -5.086949825286865,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "expressed in breast or breast cancer tissue, or show expression correlation to major breast cancer associated genes.",
            "probability": 0.008944696575934599,
            "start_logit": -5.3793559074401855,
            "end_logit": -3.9784352779388428,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "Breast Cancer",
            "probability": 0.008424415079216593,
            "start_logit": -4.7549824714660645,
            "end_logit": -4.662735462188721,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "studied the association of single nucleotide polymorphisms",
            "probability": 0.007973273355188592,
            "start_logit": -5.45503568649292,
            "end_logit": -4.017721176147461,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "expressed in breast or breast cancer tissue, or show expression correlation to major breast cancer associated genes",
            "probability": 0.0078048825254025175,
            "start_logit": -5.3793559074401855,
            "end_logit": -4.114746570587158,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "major breast cancer associated genes.We studied the association of single nucleotide polymorphisms",
            "probability": 0.007492815586788155,
            "start_logit": -5.517186164855957,
            "end_logit": -4.017721176147461,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        }
    ],
    "5e36ad01b5b409ea53000006": [
        {
            "text": "Uc.63+",
            "probability": 0.6821621511476658,
            "start_logit": 3.6905875205993652,
            "end_logit": 1.839186191558838,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "Uc.63",
            "probability": 0.28294900226023717,
            "start_logit": 3.6905875205993652,
            "end_logit": 0.9591854810714722,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "63+",
            "probability": 0.012885673329570739,
            "start_logit": -0.2785637676715851,
            "end_logit": 1.839186191558838,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "63",
            "probability": 0.005344753305236003,
            "start_logit": -0.2785637676715851,
            "end_logit": 0.9591854810714722,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "Uc",
            "probability": 0.003359488329853661,
            "start_logit": 3.6905875205993652,
            "end_logit": -3.474292516708374,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "Uc.63+ contributes to gastric cancer",
            "probability": 0.0031480782857532595,
            "start_logit": 3.6905875205993652,
            "end_logit": -3.5392889976501465,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "Uc.",
            "probability": 0.002360932098486141,
            "start_logit": 3.6905875205993652,
            "end_logit": -3.8270246982574463,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "Uc.63+ contributes to gastric cancer progression",
            "probability": 0.0021588993017878934,
            "start_logit": 3.6905875205993652,
            "end_logit": -3.91648268699646,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "Uc.63+ contributes to gastric cancer progression through regulation of NF-kB signaling",
            "probability": 0.0014900827140191576,
            "start_logit": 3.6905875205993652,
            "end_logit": -4.287249565124512,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "U",
            "probability": 0.0014332295180496562,
            "start_logit": 3.6905875205993652,
            "end_logit": -4.326150894165039,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "Uc.63+ contributes to gastric cancer progression through regulation of NF-kB signaling.",
            "probability": 0.0009398295456354096,
            "start_logit": 3.6905875205993652,
            "end_logit": -4.748137950897217,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "transcribed ultraconserved regions",
            "probability": 0.0005464847612213953,
            "start_logit": -0.6216108798980713,
            "end_logit": -0.9781316518783569,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "novel class of long non-coding RNAs and are involved in the development of several types of cancer.Uc.63+",
            "probability": 0.00023394519436982216,
            "start_logit": -4.28734827041626,
            "end_logit": 1.839186191558838,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "+",
            "probability": 0.00019139673987116863,
            "start_logit": -4.488086700439453,
            "end_logit": 1.839186191558838,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "a novel class of long non-coding RNAs and are involved in the development of several types of cancer.Uc.63+",
            "probability": 0.00019097337378178465,
            "start_logit": -4.490301132202148,
            "end_logit": 1.839186191558838,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "RNAs and are involved in the development of several types of cancer.Uc.63+",
            "probability": 0.00016039090604234266,
            "start_logit": -4.664821147918701,
            "end_logit": 1.839186191558838,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "involved in the development of several types of cancer.Uc.63+",
            "probability": 0.00013635859440686726,
            "start_logit": -4.827147006988525,
            "end_logit": 1.839186191558838,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "long non-coding RNAs and are involved in the development of several types of cancer.Uc.63+",
            "probability": 0.00013208175830875857,
            "start_logit": -4.85901403427124,
            "end_logit": 1.839186191558838,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "novel class of long non-coding RNAs and are involved in the development of several types of cancer.Uc.63",
            "probability": 9.703639995146765e-05,
            "start_logit": -4.28734827041626,
            "end_logit": 0.9591854810714722,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "a novel class of long non-coding RNAs and are involved in the development of several types of cancer.Uc.63",
            "probability": 7.92124357514088e-05,
            "start_logit": -4.490301132202148,
            "end_logit": 0.9591854810714722,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        }
    ],
    "5e46e8c13f5415952900000c": [
        {
            "text": "pyrimidine dimers",
            "probability": 0.9514604343544132,
            "start_logit": 4.046733379364014,
            "end_logit": 3.621640920639038,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "dimers",
            "probability": 0.03907826441745387,
            "start_logit": 0.8543016910552979,
            "end_logit": 3.621640920639038,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "buried lesions",
            "probability": 0.0034403220862171133,
            "start_logit": 1.2638988494873047,
            "end_logit": 0.7820424437522888,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "buried",
            "probability": 0.0014002773195969786,
            "start_logit": 1.2638988494873047,
            "end_logit": -0.11685235053300858,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "p",
            "probability": 0.0011702096287990729,
            "start_logit": 4.046733379364014,
            "end_logit": -3.079174280166626,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "pyrimidine",
            "probability": 0.0005873248300265637,
            "start_logit": 4.046733379364014,
            "end_logit": -3.7685344219207764,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "pyrimidine dim",
            "probability": 0.0004929113877465186,
            "start_logit": 4.046733379364014,
            "end_logit": -3.9437830448150635,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "pyrimidine dimers throughout the genome",
            "probability": 0.00047044049094372656,
            "start_logit": 4.046733379364014,
            "end_logit": -3.990442991256714,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "induced pyrimidine dimers",
            "probability": 0.00032517976907579365,
            "start_logit": -3.9346418380737305,
            "end_logit": 3.621640920639038,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "ers",
            "probability": 0.00030488744722205935,
            "start_logit": -3.999077320098877,
            "end_logit": 3.621640920639038,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "ine dimers",
            "probability": 0.00023299856039381164,
            "start_logit": -4.2679877281188965,
            "end_logit": 3.621640920639038,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "DNA-binding protein (UV-DDB) complex detects UV-light-induced pyrimidine dimers",
            "probability": 0.0002284391239710335,
            "start_logit": -4.287750244140625,
            "end_logit": 3.621640920639038,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "pyrimidine dimers throughout the genome;",
            "probability": 0.0001842474808220844,
            "start_logit": 4.046733379364014,
            "end_logit": -4.92783260345459,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "buried lesions that face the histone core",
            "probability": 0.0001680626510463222,
            "start_logit": 1.2638988494873047,
            "end_logit": -2.23694109916687,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "yrimidine dimers",
            "probability": 0.0001618605823352504,
            "start_logit": -4.632284641265869,
            "end_logit": 3.621640920639038,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "idine dimers",
            "probability": 9.334178562628275e-05,
            "start_logit": -5.1827521324157715,
            "end_logit": 3.621640920639038,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "buried lesions that face the histone core,",
            "probability": 8.525212313614339e-05,
            "start_logit": 1.2638988494873047,
            "end_logit": -2.9156649112701416,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "lesions",
            "probability": 7.597929283630605e-05,
            "start_logit": -2.5489606857299805,
            "end_logit": 0.7820424437522888,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "dim",
            "probability": 2.0244795105749573e-05,
            "start_logit": 0.8543016910552979,
            "end_logit": -3.9437830448150635,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "dimers throughout the genome",
            "probability": 1.9321873231911853e-05,
            "start_logit": 0.8543016910552979,
            "end_logit": -3.990442991256714,
            "question_text": "List types of DNA lesions caused by UV light."
        }
    ],
    "5cd96eb2a49efeb44c000003": [
        {
            "text": "dynamic behavior features",
            "probability": 0.11780733354305471,
            "start_logit": -3.3235297203063965,
            "end_logit": -3.917598009109497,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "CNN-IndRNN",
            "probability": 0.10358106663673365,
            "start_logit": -3.286565065383911,
            "end_logit": -4.083258628845215,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "Neural Net",
            "probability": 0.08446740904079389,
            "start_logit": -2.836613178253174,
            "end_logit": -4.737199306488037,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "Neural Net-work (IndRNN) algorithm",
            "probability": 0.07699273471815603,
            "start_logit": -2.836613178253174,
            "end_logit": -4.8298540115356445,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "Neural Net-work (IndRNN)",
            "probability": 0.06218680584036782,
            "start_logit": -2.836613178253174,
            "end_logit": -5.043422222137451,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "Recurrent Neural Net",
            "probability": 0.05787881580358527,
            "start_logit": -3.214627504348755,
            "end_logit": -4.737199306488037,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "Recurrent Neural Net-work (IndRNN) algorithm",
            "probability": 0.052757014351112554,
            "start_logit": -3.214627504348755,
            "end_logit": -4.8298540115356445,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "CNN-IndRNN classification model is constructed by improving the Independently Recurrent Neural Net-work (IndRNN)",
            "probability": 0.04439574691102774,
            "start_logit": -3.286565065383911,
            "end_logit": -4.930469512939453,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "Recurrent Neural Net-work (IndRNN)",
            "probability": 0.04261168563735243,
            "start_logit": -3.214627504348755,
            "end_logit": -5.043422222137451,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "Neural Net-work (IndRNN) algorithm and applies to open source software security vulnerability detection",
            "probability": 0.04174228390741392,
            "start_logit": -2.836613178253174,
            "end_logit": -5.442050457000732,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "Neural",
            "probability": 0.04069789799151432,
            "start_logit": -2.836613178253174,
            "end_logit": -5.46738862991333,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "IndRNN) algorithm",
            "probability": 0.040364204877643736,
            "start_logit": -3.4823808670043945,
            "end_logit": -4.8298540115356445,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "dynamic behavior features.Open source software security vulnerability detection based on dynamic behavior features",
            "probability": 0.035820768565277335,
            "start_logit": -3.914438486099243,
            "end_logit": -4.5172119140625,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "IndRNN)",
            "probability": 0.03260204980139425,
            "start_logit": -3.4823808670043945,
            "end_logit": -5.043422222137451,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "Open source software security vulnerability detection based on dynamic behavior features",
            "probability": 0.03224866263344222,
            "start_logit": -4.019489765167236,
            "end_logit": -4.5172119140625,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "Recurrent Neural Net-work (IndRNN) algorithm and applies to open source software security vulnerability detection",
            "probability": 0.02860267633320394,
            "start_logit": -3.214627504348755,
            "end_logit": -5.442050457000732,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "Recurrent Neural",
            "probability": 0.027887041501490108,
            "start_logit": -3.214627504348755,
            "end_logit": -5.46738862991333,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "IndRNN",
            "probability": 0.02784355911358852,
            "start_logit": -4.60031795501709,
            "end_logit": -4.083258628845215,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "CNN-IndRNN classification model is constructed by improving the Independently Recurrent Neural Net-work (IndRNN) algorithm",
            "probability": 0.027209518528856138,
            "start_logit": -3.286565065383911,
            "end_logit": -5.420046329498291,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "CNN-IndRNN classification model is constructed by improving the Independently Recurrent Neural Net",
            "probability": 0.02230272426399144,
            "start_logit": -4.168270111083984,
            "end_logit": -4.737199306488037,
            "question_text": "Which software are used for the detection of selective sweeps?"
        }
    ],
    "5c70273c7c78d69471000061": [
        {
            "text": "systemic lupus erythematosus",
            "probability": 0.5508657859961865,
            "start_logit": -1.8588470220565796,
            "end_logit": -1.5263398885726929,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "systemic lupus",
            "probability": 0.10779154373550864,
            "start_logit": -1.8588470220565796,
            "end_logit": -3.1576318740844727,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "lupus erythematosus",
            "probability": 0.08411197934620215,
            "start_logit": -3.738189220428467,
            "end_logit": -1.5263398885726929,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "At least half of patients with systemic lupus erythematosus",
            "probability": 0.056122748289760216,
            "start_logit": -4.142796993255615,
            "end_logit": -1.5263398885726929,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "systemic lupus erythematosus (SLE) develop organ damage as a consequence of autoimmune disease",
            "probability": 0.03155255282425295,
            "start_logit": -1.8588470220565796,
            "end_logit": -4.386176586151123,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "systemic lupus erythematosus (SLE) develop organ damage",
            "probability": 0.029748889785538735,
            "start_logit": -1.8588470220565796,
            "end_logit": -4.44503927230835,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "half of patients with systemic lupus erythematosus",
            "probability": 0.02083081300560102,
            "start_logit": -5.133904933929443,
            "end_logit": -1.5263398885726929,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "lupus",
            "probability": 0.016458746088178936,
            "start_logit": -3.738189220428467,
            "end_logit": -3.1576318740844727,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "sus",
            "probability": 0.014226475525511333,
            "start_logit": -5.515233516693115,
            "end_logit": -1.5263398885726929,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "erythematosus",
            "probability": 0.013948656483951176,
            "start_logit": -5.534955024719238,
            "end_logit": -1.5263398885726929,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "systemic lupus erythematosus (SLE) develop organ damage as a consequence of autoimmune",
            "probability": 0.013499145522549404,
            "start_logit": -1.8588470220565796,
            "end_logit": -5.235204696655273,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "At least half of patients with systemic lupus",
            "probability": 0.010981908534930342,
            "start_logit": -4.142796993255615,
            "end_logit": -3.1576318740844727,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "systemic",
            "probability": 0.01083225622314821,
            "start_logit": -1.8588470220565796,
            "end_logit": -5.455302715301514,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "This study synthesised evidence on the association between organ damage and mortality",
            "probability": 0.006578187201471161,
            "start_logit": -3.9087471961975098,
            "end_logit": -3.9041717052459717,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "autoimmune disease or long-term therapeutic steroid use.This study synthesised evidence on the association between organ damage and mortality",
            "probability": 0.0060919306951170244,
            "start_logit": -3.985541343688965,
            "end_logit": -3.9041717052459717,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "This study synthesised evidence on the association between organ damage and mortality in patients with SLE.",
            "probability": 0.0060239182982749,
            "start_logit": -3.9087471961975098,
            "end_logit": -3.9921929836273193,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "mortality",
            "probability": 0.005423675224821077,
            "start_logit": -4.1017327308654785,
            "end_logit": -3.9041717052459717,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "synthesised evidence on the association between organ damage and mortality",
            "probability": 0.005126327853373403,
            "start_logit": -4.158116817474365,
            "end_logit": -3.9041717052459717,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "mortality in patients with SLE.",
            "probability": 0.004966683894826393,
            "start_logit": -4.1017327308654785,
            "end_logit": -3.9921929836273193,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "lupus erythematosus (SLE) develop organ damage as a consequence of autoimmune disease",
            "probability": 0.0048177754707966,
            "start_logit": -3.738189220428467,
            "end_logit": -4.386176586151123,
            "question_text": "Which organs are primarily damaged in SLE?"
        }
    ],
    "5c7a4ed5d774d04240000008": [
        {
            "text": "diagnostic",
            "probability": 0.2108680488947726,
            "start_logit": 5.45297384262085,
            "end_logit": 4.4657158851623535,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "predictive",
            "probability": 0.19267438415999188,
            "start_logit": 5.299919605255127,
            "end_logit": 4.528539180755615,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "predictive, and diagnostic",
            "probability": 0.1809423260357276,
            "start_logit": 5.299919605255127,
            "end_logit": 4.4657158851623535,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "prognostic, predictive",
            "probability": 0.1552318826555602,
            "start_logit": 5.083837985992432,
            "end_logit": 4.528539180755615,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "prognostic, predictive, and diagnostic",
            "probability": 0.1457797207711774,
            "start_logit": 5.083837985992432,
            "end_logit": 4.4657158851623535,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "prognostic",
            "probability": 0.08268312310820167,
            "start_logit": 5.083837985992432,
            "end_logit": 3.898634672164917,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "diagnostic method",
            "probability": 0.00939877774396808,
            "start_logit": 5.45297384262085,
            "end_logit": 1.3550629615783691,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "predictive, and diagnostic method",
            "probability": 0.008064933098209985,
            "start_logit": 5.299919605255127,
            "end_logit": 1.3550629615783691,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "prognostic, predictive, and diagnostic method",
            "probability": 0.00649767094772028,
            "start_logit": 5.083837985992432,
            "end_logit": 1.3550629615783691,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "molecular analysis",
            "probability": 0.0019216679296723371,
            "start_logit": 2.702484607696533,
            "end_logit": 2.5181660652160645,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "predictive,",
            "probability": 0.0009629409484477754,
            "start_logit": 5.299919605255127,
            "end_logit": -0.7702256441116333,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "predict",
            "probability": 0.0009099968244563497,
            "start_logit": 5.299919605255127,
            "end_logit": -0.8267766237258911,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "prognostic, predictive,",
            "probability": 0.0007758121919806177,
            "start_logit": 5.083837985992432,
            "end_logit": -0.7702256441116333,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "prognostic, predict",
            "probability": 0.0007331567239038967,
            "start_logit": 5.083837985992432,
            "end_logit": -0.8267766237258911,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "crucial prognostic, predictive",
            "probability": 0.0006120550181507666,
            "start_logit": -0.45201513171195984,
            "end_logit": 4.528539180755615,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "crucial prognostic, predictive, and diagnostic",
            "probability": 0.0005747866231874289,
            "start_logit": -0.45201513171195984,
            "end_logit": 4.4657158851623535,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "molecular analysis of tumors is routinely required for treatment decisions",
            "probability": 0.0004676285455533844,
            "start_logit": 2.702484607696533,
            "end_logit": 1.1048915386199951,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "crucial prognostic",
            "probability": 0.000326006613776901,
            "start_logit": -0.45201513171195984,
            "end_logit": 3.898634672164917,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "liquid biopsy will be a crucial prognostic, predictive",
            "probability": 0.00029656973681512465,
            "start_logit": -1.1765549182891846,
            "end_logit": 4.528539180755615,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "liquid biopsy will be a crucial prognostic, predictive, and diagnostic",
            "probability": 0.0002785114287251212,
            "start_logit": -1.1765549182891846,
            "end_logit": 4.4657158851623535,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        }
    ],
    "5c7006037c78d6947100005d": [
        {
            "text": "serum amyloid A",
            "probability": 0.3729227925792112,
            "start_logit": 2.25295090675354,
            "end_logit": 1.7696833610534668,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "amyloid A",
            "probability": 0.2932051769600512,
            "start_logit": 2.0124521255493164,
            "end_logit": 1.7696833610534668,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "erythrocyte sedimentation rate",
            "probability": 0.24110692963122035,
            "start_logit": 2.107609987258911,
            "end_logit": 1.4788933992385864,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "erythrocyte sedimentation rate (ESR), and hypersensitive C-reactive protein",
            "probability": 0.052289513547761235,
            "start_logit": 2.107609987258911,
            "end_logit": -0.049551282078027725,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "hypersensitive C-reactive protein",
            "probability": 0.01780048395161695,
            "start_logit": 1.0300397872924805,
            "end_logit": -0.049551282078027725,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "erythrocyte sedimentation rate (ESR)",
            "probability": 0.003685635876431561,
            "start_logit": 2.107609987258911,
            "end_logit": -2.701904058456421,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "C-reactive protein",
            "probability": 0.003012199623732833,
            "start_logit": -0.7465152740478516,
            "end_logit": -0.049551282078027725,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "serum amyloid A (SAA",
            "probability": 0.0028925411483035034,
            "start_logit": 2.25295090675354,
            "end_logit": -3.089552640914917,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "amyloid A (SAA",
            "probability": 0.002274218835987116,
            "start_logit": 2.0124521255493164,
            "end_logit": -3.089552640914917,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "serum",
            "probability": 0.0018200418519875672,
            "start_logit": 2.25295090675354,
            "end_logit": -3.552828550338745,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "sedimentation rate",
            "probability": 0.001595549558524242,
            "start_logit": -2.910412311553955,
            "end_logit": 1.4788933992385864,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "erythrocyte sedimentation rate (ESR), and hypersensitive C-reactive protein (Hs-CRP)",
            "probability": 0.0014393607758640867,
            "start_logit": 2.107609987258911,
            "end_logit": -3.642148017883301,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "the erythrocyte sedimentation rate",
            "probability": 0.0010281664020384172,
            "start_logit": -3.349853515625,
            "end_logit": 1.4788933992385864,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "SAA were significantly correlated with the SLEDAI-2K scores, the erythrocyte sedimentation rate",
            "probability": 0.0009572155524657042,
            "start_logit": -2.4993085861206055,
            "end_logit": 0.5568447709083557,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "serum amyloid A (SAA)",
            "probability": 0.0008643299965373733,
            "start_logit": 2.25295090675354,
            "end_logit": -4.297488689422607,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "er",
            "probability": 0.0007380164306022603,
            "start_logit": 2.107609987258911,
            "end_logit": -4.310136318206787,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "amyloid A (SAA)",
            "probability": 0.0006795670166306384,
            "start_logit": 2.0124521255493164,
            "end_logit": -4.297488689422607,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "SLE Disease Activity Index 2000",
            "probability": 0.0006669139058497501,
            "start_logit": -1.0617531538009644,
            "end_logit": -1.2420783042907715,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "A",
            "probability": 0.0005313567443997828,
            "start_logit": -4.300742149353027,
            "end_logit": 1.7696833610534668,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "hypersensitive C-reactive protein (Hs-CRP)",
            "probability": 0.0004899896107840645,
            "start_logit": 1.0300397872924805,
            "end_logit": -3.642148017883301,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        }
    ],
    "5c74305d7c78d694710000a4": [
        {
            "text": "RIN/G3BPs",
            "probability": 0.39967944748265244,
            "start_logit": 3.3320608139038086,
            "end_logit": 1.9753669500350952,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "RIN",
            "probability": 0.3850661229842417,
            "start_logit": 3.3320608139038086,
            "end_logit": 1.9381191730499268,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "G3BPs",
            "probability": 0.0833300439106824,
            "start_logit": 1.764207124710083,
            "end_logit": 1.9753669500350952,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "RIN/G3BPs into SGs sequesters them away from their short target mRNAs.G3BP RNA",
            "probability": 0.03720576278073428,
            "start_logit": 3.3320608139038086,
            "end_logit": -0.398832231760025,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "RIN/G3BPs into SGs sequesters them away from their short target mRNAs",
            "probability": 0.022578121425819532,
            "start_logit": 3.3320608139038086,
            "end_logit": -0.8983145356178284,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "RIN/G3BPs into SGs sequesters them away from their short target mRNAs.G3BP",
            "probability": 0.020233924145910024,
            "start_logit": 3.3320608139038086,
            "end_logit": -1.0079352855682373,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "RIN/G3BPs into SGs",
            "probability": 0.010093920484522631,
            "start_logit": 3.3320608139038086,
            "end_logit": -1.7033625841140747,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "G3BPs into SGs sequesters them away from their short target mRNAs.G3BP RNA",
            "probability": 0.007757111019283992,
            "start_logit": 1.764207124710083,
            "end_logit": -0.398832231760025,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "RNA",
            "probability": 0.007190268340441341,
            "start_logit": 1.6883256435394287,
            "end_logit": -0.398832231760025,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "G3BPs into SGs sequesters them away from their short target mRNAs",
            "probability": 0.004707362016446748,
            "start_logit": 1.764207124710083,
            "end_logit": -0.8983145356178284,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "G3BPs into SGs sequesters them away from their short target mRNAs.G3BP",
            "probability": 0.004218615188205999,
            "start_logit": 1.764207124710083,
            "end_logit": -1.0079352855682373,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "G3BPs into SGs sequesters them away from their short target mRNAs.G3BP RNA-binding proteins",
            "probability": 0.003659801715153857,
            "start_logit": 1.764207124710083,
            "end_logit": -1.1500332355499268,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "RNA-binding proteins",
            "probability": 0.0033923655777705567,
            "start_logit": 1.6883256435394287,
            "end_logit": -1.1500332355499268,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "RIN/G3BPs into SGs sequesters them away from their short target",
            "probability": 0.0024140223980952556,
            "start_logit": 3.3320608139038086,
            "end_logit": -3.1340014934539795,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "RIN/G3BPs into SGs sequesters them away from their short target mRNAs.",
            "probability": 0.002255596555384693,
            "start_logit": 3.3320608139038086,
            "end_logit": -3.2018814086914062,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "G3BPs into SGs",
            "probability": 0.0021045036028346582,
            "start_logit": 1.764207124710083,
            "end_logit": -1.7033625841140747,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "G3BP RNA",
            "probability": 0.0014568969328776226,
            "start_logit": 0.09190593659877777,
            "end_logit": -0.398832231760025,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "RIN-bound mRNAs",
            "probability": 0.001176433517654311,
            "start_logit": 2.040634870529175,
            "end_logit": -2.561382532119751,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "G3BP",
            "probability": 0.0007923165613343999,
            "start_logit": 0.09190593659877777,
            "end_logit": -1.0079352855682373,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "G3BP RNA-binding proteins",
            "probability": 0.0006873633599535713,
            "start_logit": 0.09190593659877777,
            "end_logit": -1.1500332355499268,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        }
    ],
    "5c7a4a31d774d04240000006": [
        {
            "text": "varied among tumour types",
            "probability": 0.714053548246921,
            "start_logit": 0.13455067574977875,
            "end_logit": 0.6953946948051453,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "varied",
            "probability": 0.18769474883229836,
            "start_logit": 0.13455067574977875,
            "end_logit": -0.6407462954521179,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "increased compared to those of healthy controls and varied among tumour types",
            "probability": 0.03339830197580828,
            "start_logit": -2.9279022216796875,
            "end_logit": 0.6953946948051453,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "tumour types",
            "probability": 0.016595195367152996,
            "start_logit": -3.6272940635681152,
            "end_logit": 0.6953946948051453,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "varied among tumour types.Therefore, our newly developed system shows potential for accurate",
            "probability": 0.011454634703215847,
            "start_logit": 0.13455067574977875,
            "end_logit": -3.437168836593628,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "levels were increased compared to those of healthy controls and varied among tumour types",
            "probability": 0.010623917989721956,
            "start_logit": -4.073299407958984,
            "end_logit": 0.6953946948051453,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "increased compared to those of healthy controls and varied",
            "probability": 0.008779013725462036,
            "start_logit": -2.9279022216796875,
            "end_logit": -0.6407462954521179,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "soluble PD-1, PD-L1, and CTLA-4 levels were increased compared to those of healthy controls and varied",
            "probability": 0.004099725325102004,
            "start_logit": -3.6893463134765625,
            "end_logit": -0.6407462954521179,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "levels were increased compared to those of healthy controls and varied",
            "probability": 0.0027925827461979798,
            "start_logit": -4.073299407958984,
            "end_logit": -0.6407462954521179,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "increased",
            "probability": 0.0012861284682826857,
            "start_logit": -2.9279022216796875,
            "end_logit": -2.561473846435547,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "immune checkpoint-associated molecules such as PD-1, PD-L1, and CTLA-4 would be critical",
            "probability": 0.0011646961420825595,
            "start_logit": -1.8355385065078735,
            "end_logit": -3.753013849258423,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "immune checkpoint",
            "probability": 0.0011141172638982832,
            "start_logit": -1.8355385065078735,
            "end_logit": -3.7974116802215576,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "immune state of individuals",
            "probability": 0.0010370808258061393,
            "start_logit": -2.7586405277252197,
            "end_logit": -2.9459621906280518,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "immune checkpoint-associated molecules",
            "probability": 0.0010104195277602533,
            "start_logit": -1.8355385065078735,
            "end_logit": -3.895108461380005,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "immune state",
            "probability": 0.0009269075070343356,
            "start_logit": -2.7586405277252197,
            "end_logit": -3.0582735538482666,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "increased compared to those of healthy controls",
            "probability": 0.0008522213404271416,
            "start_logit": -2.9279022216796875,
            "end_logit": -2.9730193614959717,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "expression",
            "probability": 0.0008150091204752092,
            "start_logit": -2.188643217086792,
            "end_logit": -3.756925344467163,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "immune",
            "probability": 0.0008092560842207056,
            "start_logit": -2.7586405277252197,
            "end_logit": -3.194011926651001,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "expression levels of immune checkpoint",
            "probability": 0.000782671422094203,
            "start_logit": -2.188643217086792,
            "end_logit": -3.7974116802215576,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "expression levels of immune checkpoint-associated molecules",
            "probability": 0.0007098233860381786,
            "start_logit": -2.188643217086792,
            "end_logit": -3.895108461380005,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        }
    ],
    "5e360f3d158f994d3a000009": [
        {
            "text": "chronic constipation",
            "probability": 0.29886852810604775,
            "start_logit": 3.510730743408203,
            "end_logit": 3.782728433609009,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "constipation",
            "probability": 0.29373847015346516,
            "start_logit": 3.5749833583831787,
            "end_logit": 3.7011618614196777,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "hearing loss and pigmentary abnormalities",
            "probability": 0.18811474289599978,
            "start_logit": 3.827251434326172,
            "end_logit": 3.00325608253479,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "hearing loss",
            "probability": 0.1859412262704073,
            "start_logit": 3.827251434326172,
            "end_logit": 2.9916346073150635,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "pigmentary abnormalities",
            "probability": 0.025862333837708636,
            "start_logit": 1.8429869413375854,
            "end_logit": 3.00325608253479,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "hearing",
            "probability": 0.0029012940036476417,
            "start_logit": 3.827251434326172,
            "end_logit": -1.1686391830444336,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "persistent chronic constipation",
            "probability": 0.0017261941794239268,
            "start_logit": -1.6433539390563965,
            "end_logit": 3.782728433609009,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "hearing loss and pigmentary",
            "probability": 0.0006613290624133834,
            "start_logit": 3.827251434326172,
            "end_logit": -2.6472997665405273,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "hearing loss and pigmentary abnormalities with variable penetrance",
            "probability": 0.0005844985460601217,
            "start_logit": 3.827251434326172,
            "end_logit": -2.77079701423645,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "ation",
            "probability": 0.0003979023339147879,
            "start_logit": -3.1108217239379883,
            "end_logit": 3.782728433609009,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "chronic constipation since the neonatal period,",
            "probability": 0.00022859852749269072,
            "start_logit": 3.510730743408203,
            "end_logit": -3.3930633068084717,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "constipation since the neonatal period,",
            "probability": 0.0001844291134225797,
            "start_logit": 3.2960286140441895,
            "end_logit": -3.3930633068084717,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "con",
            "probability": 0.0001271707966240554,
            "start_logit": 3.5749833583831787,
            "end_logit": -4.043752193450928,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "chronic con",
            "probability": 0.0001228970263762338,
            "start_logit": 3.510730743408203,
            "end_logit": -4.013683795928955,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "chronic",
            "probability": 0.0001172142628857499,
            "start_logit": 3.510730743408203,
            "end_logit": -4.0610270500183105,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "loss and pigmentary abnormalities",
            "probability": 9.446546101549707e-05,
            "start_logit": -3.7693216800689697,
            "end_logit": 3.00325608253479,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "loss",
            "probability": 9.337398755147967e-05,
            "start_logit": -3.7693216800689697,
            "end_logit": 2.9916346073150635,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "pigmentary",
            "probability": 9.092064090994473e-05,
            "start_logit": 1.8429869413375854,
            "end_logit": -2.6472997665405273,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "pigmentary abnormalities with variable penetrance",
            "probability": 8.035785124092809e-05,
            "start_logit": 1.8429869413375854,
            "end_logit": -2.77079701423645,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "ipation",
            "probability": 6.405294339247285e-05,
            "start_logit": -4.937318325042725,
            "end_logit": 3.782728433609009,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        }
    ],
    "5e493bc06d0a277941000003": [
        {
            "text": "lung cancer",
            "probability": 0.9084690341236127,
            "start_logit": 3.582690715789795,
            "end_logit": 3.5088348388671875,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "lung cancer progression.Moreover, we exhibited that miR-543 was remarkably increased in lung cancer",
            "probability": 0.04674034593189182,
            "start_logit": 2.67236328125,
            "end_logit": 1.4520092010498047,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "lung",
            "probability": 0.033869483671958224,
            "start_logit": 3.582690715789795,
            "end_logit": 0.21958845853805542,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "lung cancer progression.Moreover, we exhibited that miR-543 was remarkably increased in lung",
            "probability": 0.0026845323145613166,
            "start_logit": 2.67236328125,
            "end_logit": -1.4050920009613037,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "cancer",
            "probability": 0.0018843109808213084,
            "start_logit": -2.595507860183716,
            "end_logit": 3.5088348388671875,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "various cancers.LINC-PINT alleviates lung cancer",
            "probability": 0.001594944937565808,
            "start_logit": -2.76223087310791,
            "end_logit": 3.5088348388671875,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "lung cancer progression via sponging miR-543 and inducing PTEN",
            "probability": 0.0015568384535383666,
            "start_logit": 3.582690715789795,
            "end_logit": -2.8602688312530518,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "lung cancer progression",
            "probability": 0.0009912174451650235,
            "start_logit": 3.582690715789795,
            "end_logit": -3.3117473125457764,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "lung cancer progression via sponging miR-543",
            "probability": 0.0007828234301554698,
            "start_logit": 3.582690715789795,
            "end_logit": -3.547774076461792,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "cancers.LINC-PINT alleviates lung cancer",
            "probability": 0.0006322963974987134,
            "start_logit": -3.687467098236084,
            "end_logit": 3.5088348388671875,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "various cancers.Here, we investigated the effects of LINC-PINT on lung cancer",
            "probability": 0.0002078354654917381,
            "start_logit": -3.7720446586608887,
            "end_logit": 2.4808008670806885,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "lung cancer.All these findings concluded that LINC-PINT exerted crucial biological roles in NSCLC",
            "probability": 0.0001746170750722026,
            "start_logit": 1.001499056816101,
            "end_logit": -2.4668941497802734,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "lung cancer,",
            "probability": 0.0001561516336809269,
            "start_logit": 1.233016014099121,
            "end_logit": -2.8101789951324463,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "cancer progression.Moreover, we exhibited that miR-543 was remarkably increased in lung cancer",
            "probability": 0.00011035858388060661,
            "start_logit": -3.376264810562134,
            "end_logit": 1.4520092010498047,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "various cancers.LINC-PINT alleviates lung",
            "probability": 5.946263382842747e-05,
            "start_logit": -2.76223087310791,
            "end_logit": 0.21958845853805542,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "cancers.LINC-PINT alleviates lung",
            "probability": 2.357323332608685e-05,
            "start_logit": -3.687467098236084,
            "end_logit": 0.21958845853805542,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "xenografts were utilized to confirm the function of LINC-PINT on lung cancer",
            "probability": 1.9235183531707282e-05,
            "start_logit": -4.423243999481201,
            "end_logit": 0.7519945502281189,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "lung cancer, which could be regulated by LINC-PINT negatively.",
            "probability": 1.6088321227230538e-05,
            "start_logit": 1.233016014099121,
            "end_logit": -5.082912921905518,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "lung cancer, which could be regulated by LINC-PINT negatively.Finally, xenografts",
            "probability": 1.5599880217400982e-05,
            "start_logit": 1.233016014099121,
            "end_logit": -5.113743305206299,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "various cancers.Here, we investigated the effects of LINC-PINT on lung",
            "probability": 1.1250302974944987e-05,
            "start_logit": -3.7720446586608887,
            "end_logit": -0.4355508089065552,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        }
    ],
    "5e2f43bafbd6abf43b000029": [
        {
            "text": "severe acute respiratory syndrome",
            "probability": 0.6303579694140331,
            "start_logit": 4.300111770629883,
            "end_logit": 4.150448322296143,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019 which causes coronavirus disease-2019",
            "probability": 0.12313819710269809,
            "start_logit": 4.300111770629883,
            "end_logit": 2.517467737197876,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019 which causes coronavirus disease",
            "probability": 0.05781722446326435,
            "start_logit": 4.300111770629883,
            "end_logit": 1.7614471912384033,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "severe acute respiratory syndrome coronavirus 2",
            "probability": 0.044251354926904636,
            "start_logit": 4.300111770629883,
            "end_logit": 1.4940464496612549,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "coronavirus disease-2019",
            "probability": 0.03756061588358591,
            "start_logit": 3.112760543823242,
            "end_logit": 2.517467737197876,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "acute respiratory syndrome",
            "probability": 0.02377684036366201,
            "start_logit": 1.0225359201431274,
            "end_logit": 4.150448322296143,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "coronavirus disease",
            "probability": 0.017635880747129726,
            "start_logit": 3.112760543823242,
            "end_logit": 1.7614471912384033,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "coronavirus disease-2019 (COVID-19",
            "probability": 0.01329042372533751,
            "start_logit": 3.112760543823242,
            "end_logit": 1.47855544090271,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "severe acute respiratory syndrome coronavirus",
            "probability": 0.00928758209498442,
            "start_logit": 4.300111770629883,
            "end_logit": -0.06716129183769226,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "coronavirus disease-2019 (COVID-19)",
            "probability": 0.006797795528535085,
            "start_logit": 3.112760543823242,
            "end_logit": 0.8081100583076477,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "respiratory syndrome",
            "probability": 0.006057505278471333,
            "start_logit": -0.34487804770469666,
            "end_logit": 4.150448322296143,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "coronavirus 2 (SARS-CoV-2) in December 2019 which causes coronavirus disease-2019",
            "probability": 0.006042402232973062,
            "start_logit": 1.2856061458587646,
            "end_logit": 2.517467737197876,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019 which causes coronavirus disease-2019",
            "probability": 0.004644721566543616,
            "start_logit": 1.0225359201431274,
            "end_logit": 2.517467737197876,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019 which causes coronavirus",
            "probability": 0.004308569866783337,
            "start_logit": 4.300111770629883,
            "end_logit": -0.8352335095405579,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "coronavirus disease-2019 (COVID-19),",
            "probability": 0.0036666488795917135,
            "start_logit": 3.112760543823242,
            "end_logit": 0.1907898187637329,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "coronavirus 2 (SARS-CoV-2) in December 2019 which causes coronavirus disease",
            "probability": 0.0028370963228393615,
            "start_logit": 1.2856061458587646,
            "end_logit": 1.7614471912384033,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "COVID-19",
            "probability": 0.002507769347081355,
            "start_logit": 1.4451104402542114,
            "end_logit": 1.47855544090271,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019 which causes coronavirus disease",
            "probability": 0.0021808416535305354,
            "start_logit": 1.0225359201431274,
            "end_logit": 1.7614471912384033,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "coronavirus 2",
            "probability": 0.0021714179037347087,
            "start_logit": 1.2856061458587646,
            "end_logit": 1.4940464496612549,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "acute respiratory syndrome coronavirus 2",
            "probability": 0.0016691426983160417,
            "start_logit": 1.0225359201431274,
            "end_logit": 1.4940464496612549,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        }
    ],
    "5e5cbf4e1af46fc130000004": [
        {
            "text": "amino acids and their analogs are capable of protecting biological systems from the toxic effects of ionizing radiation",
            "probability": 0.1836275859716278,
            "start_logit": -3.0270044803619385,
            "end_logit": -4.457245349884033,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "amino acids",
            "probability": 0.11838804685342119,
            "start_logit": -3.0270044803619385,
            "end_logit": -4.8961873054504395,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "amino acids and their analogs are capable of protecting biological systems from the toxic effects of ionizing radiation.",
            "probability": 0.1078369336262643,
            "start_logit": -3.0270044803619385,
            "end_logit": -4.989534854888916,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "amino acids and their analogs",
            "probability": 0.09183809405296157,
            "start_logit": -3.0270044803619385,
            "end_logit": -5.15012788772583,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": ".",
            "probability": 0.07719130278704135,
            "start_logit": -4.709758281707764,
            "end_logit": -3.6411144733428955,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "amino acids and their analogs are capable of protecting biological systems from the toxic effects of ionizing radiation. These radioprotective agents",
            "probability": 0.07611608992066028,
            "start_logit": -3.0270044803619385,
            "end_logit": -5.337895393371582,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "ionizing radiation",
            "probability": 0.04646354965394441,
            "start_logit": -4.401246070861816,
            "end_logit": -4.457245349884033,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": ". Numerous amino acids and their analogs are capable of protecting biological systems from the toxic effects of ionizing radiation",
            "probability": 0.034129288500180724,
            "start_logit": -4.709758281707764,
            "end_logit": -4.457245349884033,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "amino",
            "probability": 0.029580616889463316,
            "start_logit": -3.0270044803619385,
            "end_logit": -6.283035755157471,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "non-sulfhydryl-containing amino acids",
            "probability": 0.02856572124347032,
            "start_logit": -4.4576897621154785,
            "end_logit": -4.887262344360352,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "ionizing radiation.",
            "probability": 0.027286132928018816,
            "start_logit": -4.401246070861816,
            "end_logit": -4.989534854888916,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "sulfhydryl-containing compounds",
            "probability": 0.024762297466004425,
            "start_logit": -4.359584808349609,
            "end_logit": -5.1282525062561035,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "radiation",
            "probability": 0.024634903662412257,
            "start_logit": -5.035749912261963,
            "end_logit": -4.457245349884033,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": ". Numerous amino acids",
            "probability": 0.02200377347800902,
            "start_logit": -4.709758281707764,
            "end_logit": -4.8961873054504395,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": ". Numerous amino acids and their analogs are capable of protecting biological systems from the toxic effects of ionizing radiation.",
            "probability": 0.02004272832554838,
            "start_logit": -4.709758281707764,
            "end_logit": -4.989534854888916,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "derivatives as radioprotective agents.",
            "probability": 0.01992698782827227,
            "start_logit": -6.06397008895874,
            "end_logit": -3.6411144733428955,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "ionizing radiation. These radioprotective agents",
            "probability": 0.019259762659185303,
            "start_logit": -4.401246070861816,
            "end_logit": -5.337895393371582,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": ". Numerous amino acids and their analogs",
            "probability": 0.017069160881549396,
            "start_logit": -4.709758281707764,
            "end_logit": -5.15012788772583,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "non-sulfhydryl-containing amino acids are also being investigated for their radioprotective effects.",
            "probability": 0.016360847578461412,
            "start_logit": -4.4576897621154785,
            "end_logit": -5.444578647613525,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "Several non-sulfhydryl-containing amino acids",
            "probability": 0.014916175693502997,
            "start_logit": -5.10745096206665,
            "end_logit": -4.887262344360352,
            "question_text": "List approved radioprotective compounds"
        }
    ],
    "5e48100bd14c9f295d000007": [
        {
            "text": "colon, female breast",
            "probability": 0.1335094291220182,
            "start_logit": 4.91836404800415,
            "end_logit": 4.63319730758667,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "colon",
            "probability": 0.09994150697499145,
            "start_logit": 4.91836404800415,
            "end_logit": 4.3436102867126465,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "thyroid, and bladder cancer",
            "probability": 0.08565415829994193,
            "start_logit": 4.943643569946289,
            "end_logit": 4.164063453674316,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "colon, female breast, thyroid, and bladder cancer",
            "probability": 0.08351600177839878,
            "start_logit": 4.91836404800415,
            "end_logit": 4.164063453674316,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "thyroid",
            "probability": 0.07815909606487124,
            "start_logit": 4.943643569946289,
            "end_logit": 4.0724921226501465,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "colon, female breast, thyroid",
            "probability": 0.076208036311487,
            "start_logit": 4.91836404800415,
            "end_logit": 4.0724921226501465,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "thyroid, and bladder",
            "probability": 0.05496097678449095,
            "start_logit": 4.943643569946289,
            "end_logit": 3.7203691005706787,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "colon, female breast, thyroid, and bladder",
            "probability": 0.05358900403647062,
            "start_logit": 4.91836404800415,
            "end_logit": 3.7203691005706787,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "bladder cancer",
            "probability": 0.048589201154231106,
            "start_logit": 4.376727104187012,
            "end_logit": 4.164063453674316,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "thyroid, and bladder cancers",
            "probability": 0.039398778653815233,
            "start_logit": 4.943643569946289,
            "end_logit": 3.3874804973602295,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "colon, female breast, thyroid, and bladder cancers",
            "probability": 0.03841527992834184,
            "start_logit": 4.91836404800415,
            "end_logit": 3.3874804973602295,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "bladder",
            "probability": 0.031177820313908422,
            "start_logit": 4.376727104187012,
            "end_logit": 3.7203691005706787,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "female breast",
            "probability": 0.030387415485589476,
            "start_logit": 3.438220500946045,
            "end_logit": 4.63319730758667,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "lung, colon, female breast",
            "probability": 0.02630453740059488,
            "start_logit": 3.293933391571045,
            "end_logit": 4.63319730758667,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "bladder cancers",
            "probability": 0.022349821879488984,
            "start_logit": 4.376727104187012,
            "end_logit": 3.3874804973602295,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "lung",
            "probability": 0.02109595338493205,
            "start_logit": 3.293933391571045,
            "end_logit": 4.412537097930908,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "breast",
            "probability": 0.020698133266519727,
            "start_logit": 3.0542354583740234,
            "end_logit": 4.63319730758667,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "lung, colon",
            "probability": 0.019690857232958686,
            "start_logit": 3.293933391571045,
            "end_logit": 4.3436102867126465,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "female breast, thyroid, and bladder cancer",
            "probability": 0.01900866075470993,
            "start_logit": 3.438220500946045,
            "end_logit": 4.164063453674316,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "female breast, thyroid",
            "probability": 0.017345331172239523,
            "start_logit": 3.438220500946045,
            "end_logit": 4.0724921226501465,
            "question_text": "List the most common cancers after a radiation exposure?"
        }
    ],
    "5cf0f567a49efeb44c00000b": [
        {
            "text": "MBF",
            "probability": 0.13679518080050695,
            "start_logit": 5.458187580108643,
            "end_logit": 4.621367931365967,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "MBF (Mbp1/Swi6) and SBF",
            "probability": 0.12838052140033784,
            "start_logit": 5.458187580108643,
            "end_logit": 4.557881832122803,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "SBF",
            "probability": 0.09957064180237188,
            "start_logit": 5.204056262969971,
            "end_logit": 4.557881832122803,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "MBF and SBF in yeast.The yeast E2F functional homologs MBF",
            "probability": 0.06639904104807565,
            "start_logit": 4.735385417938232,
            "end_logit": 4.621367931365967,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Mbp1/Swi6) and SBF",
            "probability": 0.06610432662617656,
            "start_logit": 4.7944231033325195,
            "end_logit": 4.557881832122803,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "SBF in yeast.The yeast E2F functional homologs MBF",
            "probability": 0.052635104679403466,
            "start_logit": 4.503086090087891,
            "end_logit": 4.621367931365967,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "MBF (Mbp1/Swi6",
            "probability": 0.05193219174924951,
            "start_logit": 5.458187580108643,
            "end_logit": 3.6528220176696777,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "MBF (Mbp1",
            "probability": 0.048446962812310784,
            "start_logit": 5.458187580108643,
            "end_logit": 3.58335280418396,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "MBF (Mbp1/Swi6) and SBF (Swi4",
            "probability": 0.04373663898515884,
            "start_logit": 5.458187580108643,
            "end_logit": 3.481069326400757,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Swi6) and SBF",
            "probability": 0.0423635325767686,
            "start_logit": 4.3494768142700195,
            "end_logit": 4.557881832122803,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "SBF (Swi4",
            "probability": 0.03392169751710826,
            "start_logit": 5.204056262969971,
            "end_logit": 3.481069326400757,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "E2F functional homologs MBF",
            "probability": 0.027828651121199657,
            "start_logit": 3.8657689094543457,
            "end_logit": 4.621367931365967,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "MBF and SBF",
            "probability": 0.026912559969867047,
            "start_logit": 4.735385417938232,
            "end_logit": 3.718278408050537,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Mbp1/Swi6",
            "probability": 0.026740369398410836,
            "start_logit": 4.7944231033325195,
            "end_logit": 3.6528220176696777,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "MBF (Mbp1/Swi6) and SBF (Swi4/Swi6",
            "probability": 0.026581021153693558,
            "start_logit": 5.458187580108643,
            "end_logit": 2.9830806255340576,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "E2F functional homologs MBF (Mbp1/Swi6) and SBF",
            "probability": 0.02611683189349948,
            "start_logit": 3.8657689094543457,
            "end_logit": 4.557881832122803,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Mbp1",
            "probability": 0.02494579254593052,
            "start_logit": 4.7944231033325195,
            "end_logit": 3.58335280418396,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "MBF and SBF in yeast.The yeast E2F",
            "probability": 0.024552849719384293,
            "start_logit": 4.735385417938232,
            "end_logit": 3.6265132427215576,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "MBF and SBF in yeast.The yeast E2F functional homologs MBF (Mbp1",
            "probability": 0.023515681280617866,
            "start_logit": 4.735385417938232,
            "end_logit": 3.58335280418396,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Mbp1/Swi6) and SBF (Swi4",
            "probability": 0.02252040291992847,
            "start_logit": 4.7944231033325195,
            "end_logit": 3.481069326400757,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        }
    ],
    "5e30ee25fbd6abf43b00003f": [
        {
            "text": "dermatitis",
            "probability": 0.23069793142663522,
            "start_logit": 4.359216213226318,
            "end_logit": 5.391828536987305,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "dermatitis, multiple Allergies",
            "probability": 0.17610066855457307,
            "start_logit": 4.359216213226318,
            "end_logit": 5.121775150299072,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "multiple Allergies",
            "probability": 0.12274150351032599,
            "start_logit": 3.9982409477233887,
            "end_logit": 5.121775150299072,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "dermatitis, multiple Allergies, Metabolic wasting",
            "probability": 0.09397626036857296,
            "start_logit": 4.359216213226318,
            "end_logit": 4.4937615394592285,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "Severe dermatitis",
            "probability": 0.08977241583983686,
            "start_logit": 3.4153847694396973,
            "end_logit": 5.391828536987305,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "Severe dermatitis, multiple Allergies",
            "probability": 0.06852676289462903,
            "start_logit": 3.4153847694396973,
            "end_logit": 5.121775150299072,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "multiple Allergies, Metabolic wasting",
            "probability": 0.06550109994807833,
            "start_logit": 3.9982409477233887,
            "end_logit": 4.4937615394592285,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "Metabolic wasting",
            "probability": 0.06270596641240872,
            "start_logit": 3.9546306133270264,
            "end_logit": 4.4937615394592285,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "Severe dermatitis, multiple Allergies, Metabolic wasting",
            "probability": 0.036569360950525966,
            "start_logit": 3.4153847694396973,
            "end_logit": 4.4937615394592285,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "Allergies",
            "probability": 0.023738474057856077,
            "start_logit": 2.355257511138916,
            "end_logit": 5.121775150299072,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "Allergies, Metabolic wasting",
            "probability": 0.01266805536358519,
            "start_logit": 2.355257511138916,
            "end_logit": 4.4937615394592285,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "dermatitis,",
            "probability": 0.0051088840081537044,
            "start_logit": 4.359216213226318,
            "end_logit": 1.581700325012207,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "dermatitis, multiple Allergies,",
            "probability": 0.0034337050046586775,
            "start_logit": 4.359216213226318,
            "end_logit": 1.1843591928482056,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "multiple Allergies,",
            "probability": 0.002393279471009665,
            "start_logit": 3.9982409477233887,
            "end_logit": 1.1843591928482056,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "Severe dermatitis,",
            "probability": 0.0019880406244705278,
            "start_logit": 3.4153847694396973,
            "end_logit": 1.581700325012207,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "Severe dermatitis, multiple Allergies,",
            "probability": 0.001336171467352648,
            "start_logit": 3.4153847694396973,
            "end_logit": 1.1843591928482056,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "(Severe dermatitis",
            "probability": 0.0008805028649302709,
            "start_logit": -1.2091550827026367,
            "end_logit": 5.391828536987305,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "wasting",
            "probability": 0.000725929822685838,
            "start_logit": -0.5041279196739197,
            "end_logit": 4.4937615394592285,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "(Severe dermatitis, multiple Allergies",
            "probability": 0.0006721219484698663,
            "start_logit": -1.2091550827026367,
            "end_logit": 5.121775150299072,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "Allergies,",
            "probability": 0.0004628654612413388,
            "start_logit": 2.355257511138916,
            "end_logit": 1.1843591928482056,
            "question_text": "List features of the SAM syndrome."
        }
    ],
    "5e46f9683f54159529000010": [
        {
            "text": "reducing side effects",
            "probability": 0.246009922155167,
            "start_logit": -5.455663204193115,
            "end_logit": -5.220892429351807,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "minimises potential side effects",
            "probability": 0.07599592459909417,
            "start_logit": -6.252575397491455,
            "end_logit": -5.598672389984131,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "minimises potential side effects.Major advances in radiation therapy, due to improvements in engineering and computing, have made it more precise, reducing side effects",
            "probability": 0.06676037446019653,
            "start_logit": -6.759925365447998,
            "end_logit": -5.220892429351807,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "reducing side effects and improving cancer control",
            "probability": 0.06343218019956816,
            "start_logit": -5.455663204193115,
            "end_logit": -6.576292991638184,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "tumour effectively and minimises potential side effects",
            "probability": 0.058721626744954826,
            "start_logit": -6.510447025299072,
            "end_logit": -5.598672389984131,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "reducing",
            "probability": 0.05644990610143422,
            "start_logit": -5.455663204193115,
            "end_logit": -6.692910671234131,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "due to improvements in engineering and computing, have made it more precise, reducing side effects",
            "probability": 0.0519472856256936,
            "start_logit": -7.010805606842041,
            "end_logit": -5.220892429351807,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "reducing side effects and improving cancer control.As radiation therapy is needed by approximately 50% of patients with cancer",
            "probability": 0.04531916726928783,
            "start_logit": -5.455663204193115,
            "end_logit": -6.912534236907959,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "cancer",
            "probability": 0.04403597095474793,
            "start_logit": -6.237367153167725,
            "end_logit": -6.159553527832031,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "reducing side effects and improving cancer control.",
            "probability": 0.04265148407313157,
            "start_logit": -5.455663204193115,
            "end_logit": -6.973202228546143,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "radiation therapy targets the tumour effectively and minimises potential side effects",
            "probability": 0.03914282265663198,
            "start_logit": -6.9160380363464355,
            "end_logit": -5.598672389984131,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "cancer there needs to be ongoing research to ensure that radiation therapy targets the tumour effectively and minimises potential side effects",
            "probability": 0.0345279070030546,
            "start_logit": -7.041487216949463,
            "end_logit": -5.598672389984131,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "minimises potential side effects.Major advances in radiation therapy,",
            "probability": 0.029032534622785933,
            "start_logit": -6.252575397491455,
            "end_logit": -6.560935020446777,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "potential side effects",
            "probability": 0.026415787493512418,
            "start_logit": -7.309293270111084,
            "end_logit": -5.598672389984131,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "tumour effectively and minimises potential side effects.Major advances in radiation therapy,",
            "probability": 0.022433277449716488,
            "start_logit": -6.510447025299072,
            "end_logit": -6.560935020446777,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "potential side effects.Major advances in radiation therapy, due to improvements in engineering and computing, have made it more precise, reducing side effects",
            "probability": 0.02185929036433359,
            "start_logit": -7.309293270111084,
            "end_logit": -5.788008213043213,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "minimises potential side effects.Major advances in radiation therapy, due to improvements in engineering and computing, have made it more precise, reducing",
            "probability": 0.02146603406930052,
            "start_logit": -6.252575397491455,
            "end_logit": -6.862880229949951,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "tumour effectively",
            "probability": 0.019613021865684536,
            "start_logit": -6.510447025299072,
            "end_logit": -6.695286750793457,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "radiation therapy is needed by approximately 50% of patients with cancer",
            "probability": 0.018345136930689232,
            "start_logit": -7.113009452819824,
            "end_logit": -6.159553527832031,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "due to improvements in engineering and computing, have made it more precise, reducing side effects and improving cancer control.",
            "probability": 0.015840345361014984,
            "start_logit": -6.8765692710876465,
            "end_logit": -6.542798042297363,
            "question_text": "List side effects of radiation therapy?"
        }
    ],
    "5e4027f948dab47f2600000d": [
        {
            "text": "meningitis",
            "probability": 0.7931588135936777,
            "start_logit": 4.70583963394165,
            "end_logit": 4.700577259063721,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "meningococciemia and meningitis",
            "probability": 0.18396477831947688,
            "start_logit": 3.244560480117798,
            "end_logit": 4.700577259063721,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "meningococciemia",
            "probability": 0.02029398356082506,
            "start_logit": 3.244560480117798,
            "end_logit": 2.49615740776062,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "itis",
            "probability": 0.0006602253784459891,
            "start_logit": -2.3853578567504883,
            "end_logit": 4.700577259063721,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "men",
            "probability": 0.0005874766511610223,
            "start_logit": 4.70583963394165,
            "end_logit": -2.5073649883270264,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "ingitis",
            "probability": 0.0005480242870073231,
            "start_logit": -2.5716195106506348,
            "end_logit": 4.700577259063721,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "mia and meningitis",
            "probability": 0.00023257270971710267,
            "start_logit": -3.4287362098693848,
            "end_logit": 4.700577259063721,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "meningitis.",
            "probability": 0.00016479756825367662,
            "start_logit": 4.70583963394165,
            "end_logit": -3.7784836292266846,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "meningococciemia and men",
            "probability": 0.0001362589812360973,
            "start_logit": 3.244560480117798,
            "end_logit": -2.5073649883270264,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "meningitis. The PHAT can be used as an auxiliary method of diagnosis permitting to establish the meningococcus",
            "probability": 0.00012187547966547212,
            "start_logit": 4.70583963394165,
            "end_logit": -4.080201625823975,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "meningococciemia and meningitis.",
            "probability": 3.822304889233364e-05,
            "start_logit": 3.244560480117798,
            "end_logit": -3.7784836292266846,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "antibody titre was mose frequent in the patients with clinical manifestations of meningococciemia and meningitis",
            "probability": 3.15791739424054e-05,
            "start_logit": -5.425441265106201,
            "end_logit": 4.700577259063721,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "increase in the antibody titre was mose frequent in the patients with clinical manifestations of meningococciemia and meningitis",
            "probability": 2.857452507396551e-05,
            "start_logit": -5.525423526763916,
            "end_logit": 4.700577259063721,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "mia",
            "probability": 2.56561434792636e-05,
            "start_logit": -3.4287362098693848,
            "end_logit": 2.49615740776062,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "antibody titre was mose frequent in the patients with clinical manifestations of meningococciemia",
            "probability": 3.483640959459465e-06,
            "start_logit": -5.425441265106201,
            "end_logit": 2.49615740776062,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "increase in the antibody titre was mose frequent in the patients with clinical manifestations of meningococciemia",
            "probability": 3.1521846051551748e-06,
            "start_logit": -5.525423526763916,
            "end_logit": 2.49615740776062,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "mia and men",
            "probability": 1.7226189044914516e-07,
            "start_logit": -3.4287362098693848,
            "end_logit": -2.5073649883270264,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "itis.",
            "probability": 1.3717749207663805e-07,
            "start_logit": -2.3853578567504883,
            "end_logit": -3.7784836292266846,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "ingitis.",
            "probability": 1.1386505236393641e-07,
            "start_logit": -2.5716195106506348,
            "end_logit": -3.7784836292266846,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "itis. The PHAT can be used as an auxiliary method of diagnosis permitting to establish the meningococcus",
            "probability": 1.0144914650931916e-07,
            "start_logit": -2.3853578567504883,
            "end_logit": -4.080201625823975,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        }
    ],
    "5e5015436d0a277941000037": [
        {
            "text": "MobiDB",
            "probability": 0.9750123027748941,
            "start_logit": 3.2408013343811035,
            "end_logit": 3.525798797607422,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB includes curated annotations from other databases, indirect disorder evidence from structural data, and disorder predictions from protein sequences.",
            "probability": 0.003585003217181058,
            "start_logit": 3.2408013343811035,
            "end_logit": -2.0798919200897217,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB includes curated annotations from other databases, indirect disorder evidence from structural data, and disorder predictions from protein sequences",
            "probability": 0.0034653175527338083,
            "start_logit": 3.2408013343811035,
            "end_logit": -2.113847017288208,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "Mob",
            "probability": 0.00217345290846111,
            "start_logit": 3.2408013343811035,
            "end_logit": -2.580334186553955,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB includes curated annotations from other databases, indirect disorder evidence from structural data",
            "probability": 0.0021555206553442695,
            "start_logit": 3.2408013343811035,
            "end_logit": -2.5886189937591553,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB includes curated annotations from other databases, indirect disorder evidence from structural data, and disorder predictions",
            "probability": 0.00203830749283586,
            "start_logit": 3.2408013343811035,
            "end_logit": -2.644531488418579,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB includes curated annotations from other databases",
            "probability": 0.0017058451925547036,
            "start_logit": 3.2408013343811035,
            "end_logit": -2.8225905895233154,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiD",
            "probability": 0.0013827750330480217,
            "start_logit": 3.2408013343811035,
            "end_logit": -3.0325589179992676,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB includes curated annotations",
            "probability": 0.0013719543318721442,
            "start_logit": 3.2408013343811035,
            "end_logit": -3.040415048599243,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB includes curated annotations from other databases,",
            "probability": 0.0012432653141596865,
            "start_logit": 3.2408013343811035,
            "end_logit": -3.1389100551605225,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB includes curated annotations from other databases, indirect disorder evidence from structural data, and disorder",
            "probability": 0.001112145509426351,
            "start_logit": 3.2408013343811035,
            "end_logit": -3.2503602504730225,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB includes curated annotations from other databases, indirect disorder evidence from structural data,",
            "probability": 0.0010005010282965938,
            "start_logit": 3.2408013343811035,
            "end_logit": -3.3561503887176514,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB includes curated annotations from other databases, indirect disorder evidence from structural",
            "probability": 0.0008793548577587312,
            "start_logit": 3.2408013343811035,
            "end_logit": -3.485218048095703,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "b",
            "probability": 0.0008556804377858606,
            "start_logit": -3.7975070476531982,
            "end_logit": 3.525798797607422,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB includes",
            "probability": 0.0007784740424386034,
            "start_logit": 3.2408013343811035,
            "end_logit": -3.6070709228515625,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB includes curated annotations from other databases, indirect disorder evidence from structural data, and disorder predictions from protein",
            "probability": 0.00044705708555875523,
            "start_logit": 3.2408013343811035,
            "end_logit": -4.161720275878906,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB includes curated annotations from other databases, indirect disorder evidence",
            "probability": 0.00037842372814083644,
            "start_logit": 3.2408013343811035,
            "end_logit": -4.328392028808594,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB includes curated annotations from other",
            "probability": 0.0003769341944114517,
            "start_logit": 3.2408013343811035,
            "end_logit": -4.332335948944092,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "protein sequences.",
            "probability": 1.9162187247043538e-05,
            "start_logit": -1.990774393081665,
            "end_logit": -2.0798919200897217,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "protein sequences",
            "probability": 1.852245585100636e-05,
            "start_logit": -1.990774393081665,
            "end_logit": -2.113847017288208,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        }
    ],
    "5e4f0a4f6d0a277941000031": [
        {
            "text": "Immunoglobulin Heavy Constant Gamma",
            "probability": 0.4560166805165522,
            "start_logit": 0.34285762906074524,
            "end_logit": -1.048790454864502,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "Immunoglobulin Heavy Constant",
            "probability": 0.19132943469823252,
            "start_logit": 0.34285762906074524,
            "end_logit": -1.917323112487793,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "Constant Gamma",
            "probability": 0.10027746593786926,
            "start_logit": -1.1717307567596436,
            "end_logit": -1.048790454864502,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "Heavy Constant Gamma",
            "probability": 0.07582063936981366,
            "start_logit": -1.4513012170791626,
            "end_logit": -1.048790454864502,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "Constant",
            "probability": 0.04207309006576437,
            "start_logit": -1.1717307567596436,
            "end_logit": -1.917323112487793,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "Heavy Constant",
            "probability": 0.03181181892875615,
            "start_logit": -1.4513012170791626,
            "end_logit": -1.917323112487793,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "Im",
            "probability": 0.02240605003460484,
            "start_logit": 0.34285762906074524,
            "end_logit": -4.061988830566406,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "Immunoglobulin Heavy",
            "probability": 0.016467513749105447,
            "start_logit": 0.34285762906074524,
            "end_logit": -4.369930267333984,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "Diversity of Immunoglobulin Heavy Constant Gamma",
            "probability": 0.012789266291622655,
            "start_logit": -3.231065511703491,
            "end_logit": -1.048790454864502,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "Constant Gamma ( Even though immunoglobulins are critical for immune responses and human survival, the diversity",
            "probability": 0.010613810231436248,
            "start_logit": -1.1717307567596436,
            "end_logit": -3.2945754528045654,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "Heavy Constant Gamma ( Even though immunoglobulins are critical for immune responses and human survival, the diversity",
            "probability": 0.00802519160581877,
            "start_logit": -1.4513012170791626,
            "end_logit": -3.2945754528045654,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "Immunoglobulin Heavy Constant Gamma ( Even though immunoglobulins are critical for immune responses and human survival,",
            "probability": 0.005910237837269014,
            "start_logit": 0.34285762906074524,
            "end_logit": -5.394633769989014,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "Gamma",
            "probability": 0.005763055458634953,
            "start_logit": -4.028203964233398,
            "end_logit": -1.048790454864502,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "Diversity of Immunoglobulin Heavy Constant",
            "probability": 0.005365950839801584,
            "start_logit": -3.231065511703491,
            "end_logit": -1.917323112487793,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "Immunoglobulin Heavy Constant Gamma ( Even though immunoglobulins are critical for immune responses and human survival",
            "probability": 0.0037655547399651603,
            "start_logit": 0.34285762906074524,
            "end_logit": -5.845424652099609,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "Immunoglobulin Heavy Constant Gamma (",
            "probability": 0.003525329422468451,
            "start_logit": 0.34285762906074524,
            "end_logit": -5.911345958709717,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "Heavy",
            "probability": 0.002738008223458072,
            "start_logit": -1.4513012170791626,
            "end_logit": -4.369930267333984,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "Unveiling the Diversity of Immunoglobulin Heavy Constant Gamma",
            "probability": 0.0019451397759349099,
            "start_logit": -5.114337921142578,
            "end_logit": -1.048790454864502,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "iling the Diversity of Immunoglobulin Heavy Constant Gamma",
            "probability": 0.0016989020353667037,
            "start_logit": -5.24968957901001,
            "end_logit": -1.048790454864502,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "diversity",
            "probability": 0.001656860237524955,
            "start_logit": -3.0289623737335205,
            "end_logit": -3.2945754528045654,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        }
    ],
    "5e55046fb761aafe09000004": [
        {
            "text": "fezolinetant",
            "probability": 0.979159914150269,
            "start_logit": 3.2836103439331055,
            "end_logit": 1.4864360094070435,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "f",
            "probability": 0.006588461717074773,
            "start_logit": 3.2836103439331055,
            "end_logit": -3.514939069747925,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "fezolineta",
            "probability": 0.0038573329882989954,
            "start_logit": 3.2836103439331055,
            "end_logit": -4.050282955169678,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "fez",
            "probability": 0.002778685148579393,
            "start_logit": 3.2836103439331055,
            "end_logit": -4.378281116485596,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "fezolin",
            "probability": 0.0025715062313694304,
            "start_logit": 3.2836103439331055,
            "end_logit": -4.4557671546936035,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "fezolinetant were designed and synthesized.",
            "probability": 0.0015966571195554242,
            "start_logit": 3.2836103439331055,
            "end_logit": -4.932346820831299,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "fezolinetant were designed and synthesized.An isoxazolo[3,4-c]piperidine",
            "probability": 0.001003272577658214,
            "start_logit": 3.2836103439331055,
            "end_logit": -5.396991729736328,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "triazolopiperazine substructure in an NK3R antagonist fezolinetant",
            "probability": 0.000783761612177058,
            "start_logit": -3.8467350006103516,
            "end_logit": 1.4864360094070435,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "fezolinetant were designed and synthesized.An isoxazolo",
            "probability": 0.0005908843171600203,
            "start_logit": 3.2836103439331055,
            "end_logit": -5.926393985748291,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "fezolinetant were designed and synthesized.An is",
            "probability": 0.0005129390245993789,
            "start_logit": 3.2836103439331055,
            "end_logit": -6.067857265472412,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "nt",
            "probability": 0.00027236585907486956,
            "start_logit": -4.903693675994873,
            "end_logit": 1.4864360094070435,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "antagonist fezolinetant",
            "probability": 0.00012808046742156568,
            "start_logit": -5.658181190490723,
            "end_logit": 1.4864360094070435,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "azine substructure in an NK3R antagonist fezolinetant",
            "probability": 7.499782221268163e-05,
            "start_logit": -6.193380832672119,
            "end_logit": 1.4864360094070435,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "zolopiperazine substructure in an NK3R antagonist fezolinetant",
            "probability": 6.496914693583915e-05,
            "start_logit": -6.33692741394043,
            "end_logit": 1.4864360094070435,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "triazolopiperazine substructure in an NK3R antagonist f",
            "probability": 5.273687476904697e-06,
            "start_logit": -3.8467350006103516,
            "end_logit": -3.514939069747925,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "triazolopiperazine substructure in an NK3R antagonist fezolineta",
            "probability": 3.0875748464811057e-06,
            "start_logit": -3.8467350006103516,
            "end_logit": -4.050282955169678,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "triazolopiperazine substructure in an NK3R antagonist fez",
            "probability": 2.224178829535711e-06,
            "start_logit": -3.8467350006103516,
            "end_logit": -4.378281116485596,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "triazolopiperazine substructure in an NK3R antagonist fezolin",
            "probability": 2.0583439339124644e-06,
            "start_logit": -3.8467350006103516,
            "end_logit": -4.4557671546936035,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "isoxazolo[3,4-c]piperidine",
            "probability": 1.8172116044867103e-06,
            "start_logit": -3.03010892868042,
            "end_logit": -5.396991729736328,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "triazolopiperazine",
            "probability": 1.7108209220745445e-06,
            "start_logit": -3.8467350006103516,
            "end_logit": -4.640695571899414,
            "question_text": "List 3 NK3R antagonists."
        }
    ],
    "5e494b0e6d0a277941000007": [
        {
            "text": "six",
            "probability": 0.1875859628777925,
            "start_logit": -4.744269371032715,
            "end_logit": -4.880541801452637,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "16 clinical candidates and the launch of six",
            "probability": 0.11926413008481045,
            "start_logit": -5.1971659660339355,
            "end_logit": -4.880541801452637,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "six monoclonal antibodies",
            "probability": 0.10069698662043908,
            "start_logit": -4.744269371032715,
            "end_logit": -5.5026631355285645,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "16",
            "probability": 0.07417304363782082,
            "start_logit": -5.1971659660339355,
            "end_logit": -5.3554816246032715,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "16 clinical candidates and the launch of six monoclonal antibodies",
            "probability": 0.06402152019910133,
            "start_logit": -5.1971659660339355,
            "end_logit": -5.5026631355285645,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "six monoclonal antibodies (mAbs) drugs.However, no small-molecule inhibitors have been approved so far,",
            "probability": 0.06218314937962254,
            "start_logit": -4.744269371032715,
            "end_logit": -5.984694957733154,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "six monoclonal antibodies (mAbs) drugs",
            "probability": 0.057166391432962954,
            "start_logit": -4.744269371032715,
            "end_logit": -6.068812847137451,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "six monoclonal antibodies (mAbs) drugs.",
            "probability": 0.03807612393456542,
            "start_logit": -4.744269371032715,
            "end_logit": -6.475191593170166,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "16 clinical candidates and the launch of six monoclonal antibodies (mAbs) drugs",
            "probability": 0.036345469776871184,
            "start_logit": -5.1971659660339355,
            "end_logit": -6.068812847137451,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "six monoclonal antibodies (mAbs) drugs.However, no small-molecule inhibitors",
            "probability": 0.03383813227739865,
            "start_logit": -4.744269371032715,
            "end_logit": -6.593190670013428,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "launch of six",
            "probability": 0.02979261134900376,
            "start_logit": -6.5842461585998535,
            "end_logit": -4.880541801452637,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "six monoclonal antibodies (mAbs) drugs.However, no small-molecule inhibitors have been approved",
            "probability": 0.02746917838607674,
            "start_logit": -4.744269371032715,
            "end_logit": -6.8017144203186035,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "monoclonal antibodies",
            "probability": 0.02533386369059694,
            "start_logit": -6.124243259429932,
            "end_logit": -5.5026631355285645,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "16 clinical candidates and the launch of six monoclonal antibodies (mAbs) drugs.",
            "probability": 0.024208185561388713,
            "start_logit": -5.1971659660339355,
            "end_logit": -6.475191593170166,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "six monoclonal antibodies (mAbs) drugs.However, no small-molecule inhibitors have been approved so far",
            "probability": 0.024053997630687707,
            "start_logit": -4.744269371032715,
            "end_logit": -6.934477806091309,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "leading to 16 clinical candidates and the launch of six",
            "probability": 0.021886892111356814,
            "start_logit": -6.892618656158447,
            "end_logit": -4.880541801452637,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "16 clinical candidates and the launch of six monoclonal antibodies (mAbs) drugs.However, no small-molecule inhibitors",
            "probability": 0.021513738809912104,
            "start_logit": -5.1971659660339355,
            "end_logit": -6.593190670013428,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "no small-molecule inhibitors have been approved so far,",
            "probability": 0.018933354145138713,
            "start_logit": -5.924395561218262,
            "end_logit": -5.993727684020996,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "16 clinical candidates and the launch of six monoclonal antibodies (mAbs) drugs.However, no small-molecule inhibitors have been approved",
            "probability": 0.01746446063501142,
            "start_logit": -5.1971659660339355,
            "end_logit": -6.8017144203186035,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "launch of six monoclonal antibodies",
            "probability": 0.015992807459442017,
            "start_logit": -6.5842461585998535,
            "end_logit": -5.5026631355285645,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        }
    ],
    "5e4be9496d0a27794100002a": [
        {
            "text": "TKIs",
            "probability": 0.7081777946400843,
            "start_logit": 2.5798957347869873,
            "end_logit": 3.0449087619781494,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "tyrosine kinase inhibitors (TKIs",
            "probability": 0.21502376541464918,
            "start_logit": 1.3879491090774536,
            "end_logit": 3.0449087619781494,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "tyrosine kinase inhibitors",
            "probability": 0.020474425724303424,
            "start_logit": 1.3879491090774536,
            "end_logit": 0.6933367848396301,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "TKIs)",
            "probability": 0.015193389029722998,
            "start_logit": 2.5798957347869873,
            "end_logit": -0.7969260215759277,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "tyrosine kinase inhibitor",
            "probability": 0.0130781580428867,
            "start_logit": 1.3879491090774536,
            "end_logit": 0.24510371685028076,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "inhibitors (TKIs",
            "probability": 0.01285796650751035,
            "start_logit": -1.0743117332458496,
            "end_logit": 2.69038462638855,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "tyrosine kinase inhibitors (TKIs)",
            "probability": 0.004613163167931596,
            "start_logit": 1.3879491090774536,
            "end_logit": -0.7969260215759277,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "(TKIs",
            "probability": 0.002984368003542282,
            "start_logit": -2.889411449432373,
            "end_logit": 3.0449087619781494,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "kinase inhibitors (TKIs",
            "probability": 0.0024445113337937152,
            "start_logit": -3.088954210281372,
            "end_logit": 3.0449087619781494,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "KIs",
            "probability": 0.001706741287348562,
            "start_logit": -3.400949478149414,
            "end_logit": 2.9976446628570557,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "inhibitors",
            "probability": 0.000967905793003687,
            "start_logit": -1.0743117332458496,
            "end_logit": 0.10380052775144577,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "inhibitor",
            "probability": 0.0009001732455195077,
            "start_logit": -1.0743117332458496,
            "end_logit": 0.03125300630927086,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "variety of tyrosine kinase inhibitors (TKIs",
            "probability": 0.00038511061789210936,
            "start_logit": -4.582499980926514,
            "end_logit": 2.69038462638855,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "T",
            "probability": 0.0002691481238748986,
            "start_logit": 2.5798957347869873,
            "end_logit": -4.83027982711792,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "kinase inhibitors",
            "probability": 0.00023276480922683864,
            "start_logit": -3.088954210281372,
            "end_logit": 0.6933367848396301,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "inhibitors (TKIs)",
            "probability": 0.0001825749282096525,
            "start_logit": -1.8415592908859253,
            "end_logit": -0.7969260215759277,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "lung cancer therapy, many patients treated with first-line small-molecule TKIs",
            "probability": 0.00018109466607284176,
            "start_logit": -3.4365010261535645,
            "end_logit": 0.7898749709129333,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "kinase inhibitor",
            "probability": 0.0001532771546308325,
            "start_logit": -2.844651222229004,
            "end_logit": 0.03125300630927086,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "t",
            "probability": 9.194616314010013e-05,
            "start_logit": 1.3879491090774536,
            "end_logit": -4.7123918533325195,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "tyrosine kinase inhibitors (T",
            "probability": 8.172134665600737e-05,
            "start_logit": 1.3879491090774536,
            "end_logit": -4.83027982711792,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        }
    ],
    "5d36a9507bc3fee31f000005": [
        {
            "text": "T\u00a0cells",
            "probability": 0.14887471417127848,
            "start_logit": -4.734042644500732,
            "end_logit": -3.2970361709594727,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "functional human T\u00a0cells",
            "probability": 0.10622466953357618,
            "start_logit": -5.071591377258301,
            "end_logit": -3.2970361709594727,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "human T\u00a0cells",
            "probability": 0.08138165173095577,
            "start_logit": -5.337997913360596,
            "end_logit": -3.2970361709594727,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "hematopoietic stem cells",
            "probability": 0.08134103220348694,
            "start_logit": -4.112406253814697,
            "end_logit": -4.52312707901001,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "neonatal thymus",
            "probability": 0.07001343914996047,
            "start_logit": -4.3933024406433105,
            "end_logit": -4.3921942710876465,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "neonatal thymus and umbilical cord blood hematopoietic stem cells",
            "probability": 0.06142116014530385,
            "start_logit": -4.3933024406433105,
            "end_logit": -4.52312707901001,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "hematopoietic stem cells (HSCs)",
            "probability": 0.05607961868720374,
            "start_logit": -4.112406253814697,
            "end_logit": -4.895005226135254,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "HSCs into immunocompromised mice.These mice harbor functional human T\u00a0cells",
            "probability": 0.054553386131816504,
            "start_logit": -5.7379679679870605,
            "end_logit": -3.2970361709594727,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "neonatal thymus and umbilical cord blood hematopoietic stem cells (HSCs)",
            "probability": 0.04234609700621252,
            "start_logit": -4.3933024406433105,
            "end_logit": -4.895005226135254,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "hematopoietic stem cells (HSCs).Conventional humanized mouse models are made by engrafting human fetal thymus",
            "probability": 0.04005827295769604,
            "start_logit": -4.112406253814697,
            "end_logit": -5.231442451477051,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "umbilical cord blood hematopoietic stem cells",
            "probability": 0.03581081259184404,
            "start_logit": -4.932806968688965,
            "end_logit": -4.52312707901001,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "cryopreserved neonatal thymus",
            "probability": 0.030174599244822305,
            "start_logit": -5.234989166259766,
            "end_logit": -4.3921942710876465,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "hematopoietic stem cells (HSCs",
            "probability": 0.028924370970584267,
            "start_logit": -4.112406253814697,
            "end_logit": -5.557093143463135,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "cryopreserved neonatal thymus and umbilical cord blood hematopoietic stem cells",
            "probability": 0.02647147340622592,
            "start_logit": -5.234989166259766,
            "end_logit": -4.52312707901001,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "umbilical cord blood hematopoietic stem cells (HSCs)",
            "probability": 0.02468934387266649,
            "start_logit": -4.932806968688965,
            "end_logit": -4.895005226135254,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "hematopoietic stem",
            "probability": 0.02437100554279952,
            "start_logit": -4.112406253814697,
            "end_logit": -5.728383541107178,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "T\u00a0cells that have matured in the presence of human self-peptides and human leukocyte antigen molecules.The",
            "probability": 0.0226678536490046,
            "start_logit": -4.734042644500732,
            "end_logit": -5.179193496704102,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "neonatal thymus and umbilical cord blood hematopoietic stem cells (HSCs",
            "probability": 0.02184098693316405,
            "start_logit": -4.3933024406433105,
            "end_logit": -5.557093143463135,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "human leukocyte antigen molecules",
            "probability": 0.021574728586334246,
            "start_logit": -4.783467769622803,
            "end_logit": -5.179193496704102,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "NeoThy humanized mouse model created using non-fetal human tissue sources, cryopreserved neonatal thymus",
            "probability": 0.021180783485064233,
            "start_logit": -5.588895320892334,
            "end_logit": -4.3921942710876465,
            "question_text": "Which cells mature in the human thymus?"
        }
    ],
    "5e30f8abfbd6abf43b000047": [
        {
            "text": "FMS-like tyrosine kinase 3",
            "probability": 0.4132914808613936,
            "start_logit": 5.5611982345581055,
            "end_logit": 4.359714984893799,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FMS",
            "probability": 0.2309498934158626,
            "start_logit": 5.5611982345581055,
            "end_logit": 3.7777626514434814,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FMS-like tyrosine kinase 3 (FLT3",
            "probability": 0.15460613134094828,
            "start_logit": 5.5611982345581055,
            "end_logit": 3.3764426708221436,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FMS-like tyrosine kinase 3 (FLT3)",
            "probability": 0.09862760055450663,
            "start_logit": 5.5611982345581055,
            "end_logit": 2.926913022994995,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FMS-like tyrosine kinase 3 (FLT3) inhibitor, were confirmed in AML cells with FLT3",
            "probability": 0.025600020817554497,
            "start_logit": 5.5611982345581055,
            "end_logit": 1.5781550407409668,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FLT3",
            "probability": 0.024308945546204625,
            "start_logit": 3.6128711700439453,
            "end_logit": 3.474733352661133,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FLT3)",
            "probability": 0.015028962488082293,
            "start_logit": 3.679826259613037,
            "end_logit": 2.926913022994995,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "tyrosine kinase 3",
            "probability": 0.005790380029023303,
            "start_logit": 1.2932430505752563,
            "end_logit": 4.359714984893799,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FMS-like tyrosine kinase 3 (FLT3) inhibitor,",
            "probability": 0.005146025752792031,
            "start_logit": 5.5611982345581055,
            "end_logit": -0.026213405653834343,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FMS-like tyrosine kinase",
            "probability": 0.004770123926955392,
            "start_logit": 5.5611982345581055,
            "end_logit": -0.10206583887338638,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "kinase 3",
            "probability": 0.004697323570570527,
            "start_logit": 1.0840380191802979,
            "end_logit": 4.359714984893799,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FMS-like tyrosine kinase 3 (FLT3) inhibitor",
            "probability": 0.004086361625979279,
            "start_logit": 5.5611982345581055,
            "end_logit": -0.256783127784729,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FLT3) inhibitor, were confirmed in AML cells with FLT3",
            "probability": 0.0039009541994132206,
            "start_logit": 3.679826259613037,
            "end_logit": 1.5781550407409668,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "tyrosine kinase 3 (FLT3",
            "probability": 0.002166094141150263,
            "start_logit": 1.2932430505752563,
            "end_logit": 3.3764426708221436,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "kinase 3 (FLT3",
            "probability": 0.0017571981483598931,
            "start_logit": 1.0840380191802979,
            "end_logit": 3.3764426708221436,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "tyrosine kinase 3 (FLT3)",
            "probability": 0.0013818123890940565,
            "start_logit": 1.2932430505752563,
            "end_logit": 2.926913022994995,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "kinase 3 (FLT3)",
            "probability": 0.0011209661322510343,
            "start_logit": 1.0840380191802979,
            "end_logit": 2.926913022994995,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "(FLT3",
            "probability": 0.0010550597978147816,
            "start_logit": 0.5739148855209351,
            "end_logit": 3.3764426708221436,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FICZ and gilteritinib, FMS-like tyrosine kinase 3",
            "probability": 0.0008684174313638062,
            "start_logit": -0.6040376424789429,
            "end_logit": 4.359714984893799,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "3",
            "probability": 0.0008462478306799679,
            "start_logit": -0.6298978924751282,
            "end_logit": 4.359714984893799,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        }
    ],
    "5e4163b848dab47f2600000f": [
        {
            "text": "coronaviridae, and adenoviridae.The influenza",
            "probability": 0.2807203993790447,
            "start_logit": 2.400106191635132,
            "end_logit": 0.20848485827445984,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "coronavir",
            "probability": 0.14143302958054169,
            "start_logit": 2.400106191635132,
            "end_logit": -0.47704797983169556,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "coronaviridae",
            "probability": 0.13404474628449353,
            "start_logit": 2.400106191635132,
            "end_logit": -0.5307006239891052,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "influenza",
            "probability": 0.07505211346922395,
            "start_logit": 1.0809297561645508,
            "end_logit": 0.20848485827445984,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "picornaviridae, coronaviridae, and adenoviridae.The influenza",
            "probability": 0.06544470855604032,
            "start_logit": 0.9439526796340942,
            "end_logit": 0.20848485827445984,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "coronaviridae, and adenoviridae",
            "probability": 0.04446734161573194,
            "start_logit": 2.400106191635132,
            "end_logit": -1.6341192722320557,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "coronaviridae, and adenovir",
            "probability": 0.04240786356573523,
            "start_logit": 2.400106191635132,
            "end_logit": -1.6815404891967773,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "adenoviridae.The influenza",
            "probability": 0.03581086730380607,
            "start_logit": 0.34099844098091125,
            "end_logit": 0.20848485827445984,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "picornaviridae, coronavir",
            "probability": 0.03297246449339202,
            "start_logit": 0.9439526796340942,
            "end_logit": -0.47704797983169556,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "picornaviridae, coronaviridae",
            "probability": 0.03125002448508166,
            "start_logit": 0.9439526796340942,
            "end_logit": -0.5307006239891052,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "respiratory disease",
            "probability": 0.027953847722454805,
            "start_logit": 0.4328904449939728,
            "end_logit": -0.13110369443893433,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "picornaviridae",
            "probability": 0.016962969021112433,
            "start_logit": 0.9439526796340942,
            "end_logit": -1.1416881084442139,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "respiratory",
            "probability": 0.01694021243594087,
            "start_logit": 0.4328904449939728,
            "end_logit": -0.6319683194160461,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "coronaviridae, and adenoviridae.The influenza viruses",
            "probability": 0.015042583655612562,
            "start_logit": 2.400106191635132,
            "end_logit": -2.717989206314087,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "picornaviridae, coronaviridae, and adenoviridae",
            "probability": 0.010366728669312009,
            "start_logit": 0.9439526796340942,
            "end_logit": -1.6341192722320557,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "picornaviridae, coronaviridae, and adenovir",
            "probability": 0.00988659989684754,
            "start_logit": 0.9439526796340942,
            "end_logit": -1.6815404891967773,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "adenoviridae",
            "probability": 0.005672598334415381,
            "start_logit": 0.34099844098091125,
            "end_logit": -1.6341192722320557,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "adenovir",
            "probability": 0.005409875371186944,
            "start_logit": 0.34099844098091125,
            "end_logit": -1.6815404891967773,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "corona",
            "probability": 0.004139310253777058,
            "start_logit": 2.400106191635132,
            "end_logit": -4.008345127105713,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "influenza viruses",
            "probability": 0.0040217159062491846,
            "start_logit": 1.0809297561645508,
            "end_logit": -2.717989206314087,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        }
    ],
    "5e342175fbd6abf43b000064": [
        {
            "text": "clinical features of CS,",
            "probability": 0.11121343675134263,
            "start_logit": -4.578206539154053,
            "end_logit": -4.7195725440979,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "clinical features of CS",
            "probability": 0.108578245301453,
            "start_logit": -4.578206539154053,
            "end_logit": -4.7435526847839355,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "clinical features",
            "probability": 0.06783633149890707,
            "start_logit": -4.578206539154053,
            "end_logit": -5.213925838470459,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "clinical",
            "probability": 0.0626159344245732,
            "start_logit": -4.578206539154053,
            "end_logit": -5.294003963470459,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "performed in two familial and two sporadic Korean patients showing the clinical features of CS,",
            "probability": 0.05579574858221599,
            "start_logit": -5.267960071563721,
            "end_logit": -4.7195725440979,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "performed in two familial and two sporadic Korean patients showing the clinical features of CS",
            "probability": 0.05447367380511158,
            "start_logit": -5.267960071563721,
            "end_logit": -4.7435526847839355,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "clinical features of CS, and two mutations in the HLXB9 gene were identified only in the two familial cases.",
            "probability": 0.05345980972399687,
            "start_logit": -4.578206539154053,
            "end_logit": -5.452093601226807,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "sequence analysis",
            "probability": 0.04586729855139593,
            "start_logit": -5.253422260284424,
            "end_logit": -4.930055618286133,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": ",",
            "probability": 0.04191363186711389,
            "start_logit": -5.515790939331055,
            "end_logit": -4.757828235626221,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "features of CS,",
            "probability": 0.0403802598420621,
            "start_logit": -5.5913166999816895,
            "end_logit": -4.7195725440979,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "features of CS",
            "probability": 0.03942345355508403,
            "start_logit": -5.5913166999816895,
            "end_logit": -4.7435526847839355,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "was performed in two familial and two sporadic Korean patients showing the clinical features of CS,",
            "probability": 0.03921741638124212,
            "start_logit": -5.620536804199219,
            "end_logit": -4.7195725440979,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "analysis",
            "probability": 0.038707289786620906,
            "start_logit": -5.423146724700928,
            "end_logit": -4.930055618286133,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "was performed in two familial and two sporadic Korean patients showing the clinical features of CS",
            "probability": 0.03828816355574338,
            "start_logit": -5.620536804199219,
            "end_logit": -4.7435526847839355,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": ", sequence analysis",
            "probability": 0.035282381590018064,
            "start_logit": -5.515790939331055,
            "end_logit": -4.930055618286133,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "sequence analysis of the HLXB9 gene was performed in two familial and two sporadic Korean patients showing the clinical features",
            "probability": 0.034531853679083055,
            "start_logit": -5.253422260284424,
            "end_logit": -5.213925838470459,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "performed in two familial and two sporadic Korean patients showing the clinical features",
            "probability": 0.034033467606216956,
            "start_logit": -5.267960071563721,
            "end_logit": -5.213925838470459,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "sequence analysis of the HLXB9 gene was performed",
            "probability": 0.03349530052457506,
            "start_logit": -5.253422260284424,
            "end_logit": -5.244402885437012,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "performed",
            "probability": 0.03301187465803884,
            "start_logit": -5.267960071563721,
            "end_logit": -5.244402885437012,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "sequence analysis of the HLXB9 gene was performed in two familial and two sporadic Korean patients showing the clinical",
            "probability": 0.03187442831520536,
            "start_logit": -5.253422260284424,
            "end_logit": -5.294003963470459,
            "question_text": "List features of the Currarino triad."
        }
    ],
    "5e36a901b5b409ea53000005": [
        {
            "text": "uc.63",
            "probability": 0.7148153161386429,
            "start_logit": 2.6348907947540283,
            "end_logit": 1.8257555961608887,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "63",
            "probability": 0.10379066657375856,
            "start_logit": 0.7052426338195801,
            "end_logit": 1.8257555961608887,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "uc.63- and uc.280+",
            "probability": 0.04323739197490473,
            "start_logit": 2.6348907947540283,
            "end_logit": -0.9795629382133484,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "uc.63- and uc.280",
            "probability": 0.038221024812644604,
            "start_logit": 2.6348907947540283,
            "end_logit": -1.1028828620910645,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "uc.280+",
            "probability": 0.036171742425904735,
            "start_logit": 2.45646333694458,
            "end_logit": -0.9795629382133484,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "uc.280",
            "probability": 0.03197512619585193,
            "start_logit": 2.45646333694458,
            "end_logit": -1.1028828620910645,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "63- and uc.280+",
            "probability": 0.006278038022783266,
            "start_logit": 0.7052426338195801,
            "end_logit": -0.9795629382133484,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "63- and uc.280",
            "probability": 0.005549665141292422,
            "start_logit": 0.7052426338195801,
            "end_logit": -1.1028828620910645,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "u",
            "probability": 0.004017967832942058,
            "start_logit": 2.6348907947540283,
            "end_logit": -3.355492353439331,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "uc.63-",
            "probability": 0.0035449667556876866,
            "start_logit": 2.6348907947540283,
            "end_logit": -3.4807398319244385,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "analyses of T-UCR expression profiles and exploration of the efficacy of uc.63",
            "probability": 0.0021185947796392305,
            "start_logit": -3.186380386352539,
            "end_logit": 1.8257555961608887,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "uc.63- and u",
            "probability": 0.0015834515490558492,
            "start_logit": 2.6348907947540283,
            "end_logit": -4.286661624908447,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "uc.63- and uc.",
            "probability": 0.0015300048404085032,
            "start_logit": 2.6348907947540283,
            "end_logit": -4.320997714996338,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "uc.",
            "probability": 0.0013626260741168722,
            "start_logit": 2.6348907947540283,
            "end_logit": -4.436854839324951,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "expression profiles and exploration of the efficacy of uc.63",
            "probability": 0.0012372426628393764,
            "start_logit": -3.724248170852661,
            "end_logit": 1.8257555961608887,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "Comprehensive analyses of T-UCR expression profiles and exploration of the efficacy of uc.63",
            "probability": 0.0012327203250284695,
            "start_logit": -3.727910041809082,
            "end_logit": 1.8257555961608887,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "profiles and exploration of the efficacy of uc.63",
            "probability": 0.0009348489519214169,
            "start_logit": -4.0045037269592285,
            "end_logit": 1.8257555961608887,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "uc.63- and uc.280+ as biomarkers",
            "probability": 0.00083141537387344,
            "start_logit": 2.6348907947540283,
            "end_logit": -4.930894374847412,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "exploration of the efficacy of uc.63",
            "probability": 0.0008219534452218591,
            "start_logit": -4.133204936981201,
            "end_logit": 1.8257555961608887,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "uc",
            "probability": 0.0007452361234819233,
            "start_logit": 2.6348907947540283,
            "end_logit": -5.040322780609131,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        }
    ],
    "5e3a6a4eb5b409ea53000016": [
        {
            "text": "facial nucleus lesion",
            "probability": 0.3649236395941529,
            "start_logit": 0.561156690120697,
            "end_logit": -0.288919061422348,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "facial nucleus",
            "probability": 0.09953526449271224,
            "start_logit": 0.561156690120697,
            "end_logit": -1.5880951881408691,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "ipsilateral facial nucleus lesion",
            "probability": 0.06910416991754037,
            "start_logit": -1.1029163599014282,
            "end_logit": -0.288919061422348,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "intravenous steroids showed significant improvement in his symptoms",
            "probability": 0.059023719679726645,
            "start_logit": -1.2908508777618408,
            "end_logit": -0.258660227060318,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "Treatment with intravenous steroids showed significant improvement in his symptoms",
            "probability": 0.054319922033201,
            "start_logit": -1.373899221420288,
            "end_logit": -0.258660227060318,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "facial",
            "probability": 0.043519757314155375,
            "start_logit": 0.561156690120697,
            "end_logit": -2.4153921604156494,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "facial nucleus lesion.",
            "probability": 0.037132890596657864,
            "start_logit": 0.561156690120697,
            "end_logit": -2.574104070663452,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "symptoms",
            "probability": 0.035947344376245215,
            "start_logit": -1.7867350578308105,
            "end_logit": -0.258660227060318,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "intravenous steroids",
            "probability": 0.03422308931587268,
            "start_logit": -1.2908508777618408,
            "end_logit": -0.8036990761756897,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "Treatment with intravenous steroids",
            "probability": 0.03149573685732995,
            "start_logit": -1.373899221420288,
            "end_logit": -0.8036990761756897,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "intravenous steroids showed significant improvement",
            "probability": 0.029926501767605276,
            "start_logit": -1.2908508777618408,
            "end_logit": -0.9378551840782166,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "improvement in his symptoms",
            "probability": 0.028182148107179464,
            "start_logit": -2.0301015377044678,
            "end_logit": -0.258660227060318,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "Treatment with intravenous steroids showed significant improvement",
            "probability": 0.027541558742207334,
            "start_logit": -1.373899221420288,
            "end_logit": -0.9378551840782166,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "ipsilateral facial nucleus",
            "probability": 0.01884860580131603,
            "start_logit": -1.1029163599014282,
            "end_logit": -1.5880951881408691,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "steroids showed significant improvement in his symptoms",
            "probability": 0.015231997718644811,
            "start_logit": -2.6453919410705566,
            "end_logit": -0.258660227060318,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "improvement",
            "probability": 0.014289053785847843,
            "start_logit": -2.0301015377044678,
            "end_logit": -0.9378551840782166,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "an ipsilateral facial nucleus lesion",
            "probability": 0.01159207983448042,
            "start_logit": -2.888209342956543,
            "end_logit": -0.288919061422348,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "steroids",
            "probability": 0.008831805606507726,
            "start_logit": -2.6453919410705566,
            "end_logit": -0.8036990761756897,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "ipsilateral facial",
            "probability": 0.008241167131710532,
            "start_logit": -1.1029163599014282,
            "end_logit": -2.4153921604156494,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "as a combination of one-and-a-half syndrome and an ipsilateral facial nucleus lesion",
            "probability": 0.00808954732690632,
            "start_logit": -3.2479586601257324,
            "end_logit": -0.288919061422348,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        }
    ],
    "5e475d3035b8f0833c000002": [
        {
            "text": "Clinical",
            "probability": 0.2797013865836283,
            "start_logit": -1.4780031442642212,
            "end_logit": -2.2233662605285645,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "Clinical Factors Associated with Short-Stay Laparoscopic Appendectomy.The aim of this study was to assess preoperative clinical factors",
            "probability": 0.18866057078251408,
            "start_logit": -1.4780031442642212,
            "end_logit": -2.6171393394470215,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "Clinical Factors",
            "probability": 0.17210006334858743,
            "start_logit": -1.4780031442642212,
            "end_logit": -2.709012746810913,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "Clinical Factors Associated with Short-Stay Laparoscopic Appendectomy.The aim of this study was to assess preoperative clinical",
            "probability": 0.06499964100079886,
            "start_logit": -1.4780031442642212,
            "end_logit": -3.6827070713043213,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "Clinical Factors Associated with Short-Stay Laparoscopic Appendectomy",
            "probability": 0.06099535157228198,
            "start_logit": -1.4780031442642212,
            "end_logit": -3.746291160583496,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "clinical factors",
            "probability": 0.04332174565079609,
            "start_logit": -2.9492979049682617,
            "end_logit": -2.6171393394470215,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "clinical factors associated with successful short-stay appendectomy",
            "probability": 0.028060573167816592,
            "start_logit": -2.9492979049682617,
            "end_logit": -3.0514285564422607,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "Preoperative Clinical Factors",
            "probability": 0.02383434129940545,
            "start_logit": -3.9541115760803223,
            "end_logit": -2.209852933883667,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "short-stay appendectomy (SSA) and establish a predictive score to help with patient selection.Preoperative Clinical Factors",
            "probability": 0.02085633774865923,
            "start_logit": -4.087581157684326,
            "end_logit": -2.209852933883667,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "Clinical Factors Associated with Short-Stay Laparoscopic Appendectomy.",
            "probability": 0.018389058005682885,
            "start_logit": -1.4780031442642212,
            "end_logit": -4.945333003997803,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "successful short-stay appendectomy (SSA) and establish a predictive score to help with patient selection.Preoperative Clinical Factors",
            "probability": 0.01555404918582963,
            "start_logit": -4.380918025970459,
            "end_logit": -2.209852933883667,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "clinical",
            "probability": 0.014925736221140783,
            "start_logit": -2.9492979049682617,
            "end_logit": -3.6827070713043213,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "Preoperative Clinical",
            "probability": 0.014504153161825,
            "start_logit": -4.437290668487549,
            "end_logit": -2.2233662605285645,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "preoperative clinical factors",
            "probability": 0.011333839771114474,
            "start_logit": -4.290159702301025,
            "end_logit": -2.6171393394470215,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "short-stay appendectomy",
            "probability": 0.008989724908178823,
            "start_logit": -4.087581157684326,
            "end_logit": -3.0514285564422607,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "short-stay appendectomy (SSA) and establish a predictive score to help with patient selection.Preoperative Clinical",
            "probability": 0.007414666984363501,
            "start_logit": -4.087581157684326,
            "end_logit": -3.2440507411956787,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "preoperative clinical factors associated with successful short-stay appendectomy",
            "probability": 0.007341210179600023,
            "start_logit": -4.290159702301025,
            "end_logit": -3.0514285564422607,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "Factors",
            "probability": 0.006783632784367378,
            "start_logit": -5.210726261138916,
            "end_logit": -2.209852933883667,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "successful short-stay appendectomy",
            "probability": 0.006704274982211583,
            "start_logit": -4.380918025970459,
            "end_logit": -3.0514285564422607,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "successful short-stay appendectomy (SSA) and establish a predictive score to help with patient selection.Preoperative Clinical",
            "probability": 0.005529642661197837,
            "start_logit": -4.380918025970459,
            "end_logit": -3.2440507411956787,
            "question_text": "Which factors are included in the the APPEND score?"
        }
    ],
    "5e493a3e6d0a277941000002": [
        {
            "text": "TNBL",
            "probability": 0.9801584093972949,
            "start_logit": 3.6323108673095703,
            "end_logit": 2.8671715259552,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "TNBL, and immunofluorescence against SAM68 perinucleolar body,",
            "probability": 0.005099257252565603,
            "start_logit": 3.6323108673095703,
            "end_logit": -2.3914477825164795,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "TNBL, and immunofluorescence against SAM68 perinucleolar body",
            "probability": 0.003211614754218897,
            "start_logit": 3.6323108673095703,
            "end_logit": -2.853768825531006,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "TNBL, and immunofluorescence",
            "probability": 0.002753199124338981,
            "start_logit": 3.6323108673095703,
            "end_logit": -3.007779121398926,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "RNA (smRNA) FISH against TNBL",
            "probability": 0.0021646528537596897,
            "start_logit": -2.4831433296203613,
            "end_logit": 2.8671715259552,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "TNBL,",
            "probability": 0.0017763470323660605,
            "start_logit": 3.6323108673095703,
            "end_logit": -3.445983648300171,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "TNBL, and immunofluorescence against SAM68 perinucleolar body, we",
            "probability": 0.0011620147583175948,
            "start_logit": 3.6323108673095703,
            "end_logit": -3.870387315750122,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "FISH against TNBL",
            "probability": 0.0010873954579756504,
            "start_logit": -3.1716179847717285,
            "end_logit": 2.8671715259552,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "single molecule RNA (smRNA) FISH against TNBL",
            "probability": 0.0008832587290765419,
            "start_logit": -3.37954044342041,
            "end_logit": 2.8671715259552,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "TNBL, and immunofluorescence against SAM68 perinucleolar body, we resolved the spatial complexity",
            "probability": 0.0005277913493171799,
            "start_logit": 3.6323108673095703,
            "end_logit": -4.659596920013428,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "L",
            "probability": 0.0004372116277884007,
            "start_logit": -4.0827412605285645,
            "end_logit": 2.8671715259552,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": ") FISH against TNBL",
            "probability": 0.0002948524305859215,
            "start_logit": -4.476683616638184,
            "end_logit": 2.8671715259552,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "against TNBL",
            "probability": 0.00028614512287522293,
            "start_logit": -4.506659507751465,
            "end_logit": 2.8671715259552,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "we resolved the spatial complexity of the interaction between TNBL",
            "probability": 4.891720418669773e-05,
            "start_logit": -3.5045297145843506,
            "end_logit": 0.09867178648710251,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "TNBL aggregates",
            "probability": 2.1592874235760914e-05,
            "start_logit": -0.18889614939689636,
            "end_logit": -4.034727573394775,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "perinucleolar body, we resolved the spatial complexity of the interaction between TNBL",
            "probability": 2.002709998565228e-05,
            "start_logit": -4.3975725173950195,
            "end_logit": 0.09867178648710251,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "TNBL aggregates and SAM68 bodies at the perinucleolar region.",
            "probability": 1.8865313812433392e-05,
            "start_logit": -0.18889614939689636,
            "end_logit": -4.169765949249268,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": ", we resolved the spatial complexity of the interaction between TNBL",
            "probability": 1.6465290842961405e-05,
            "start_logit": -4.593404293060303,
            "end_logit": 0.09867178648710251,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "TNBL aggregates and SAM68 bodies at the perinucleolar region",
            "probability": 1.6429342531676896e-05,
            "start_logit": -0.18889614939689636,
            "end_logit": -4.3080220222473145,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "against SAM68 perinucleolar body, we resolved the spatial complexity of the interaction between TNBL",
            "probability": 1.555298392380354e-05,
            "start_logit": -4.650406360626221,
            "end_logit": 0.09867178648710251,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        }
    ],
    "5e6e4a6c51b80c9423000002": [
        {
            "text": "Wdr5",
            "probability": 0.3720751912069232,
            "start_logit": 3.2132561206817627,
            "end_logit": 2.7159688472747803,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Wdr5 and Utx",
            "probability": 0.18174251090487303,
            "start_logit": 3.2132561206817627,
            "end_logit": 1.9994637966156006,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Runx2/p57 P1 promoter is accompanied by the simultaneous interaction of Wdr5",
            "probability": 0.17537684882916454,
            "start_logit": 2.461097240447998,
            "end_logit": 2.7159688472747803,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Utx",
            "probability": 0.11706218552168679,
            "start_logit": 2.7733705043792725,
            "end_logit": 1.9994637966156006,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Runx2/p57 P1 promoter is accompanied by the simultaneous interaction of Wdr5 and Utx",
            "probability": 0.0856639453907338,
            "start_logit": 2.461097240447998,
            "end_logit": 1.9994637966156006,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Runx2",
            "probability": 0.03346356932356645,
            "start_logit": 2.461097240447998,
            "end_logit": 1.059489130973816,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Wdr5 and Utx proteins",
            "probability": 0.012802698149196965,
            "start_logit": 3.2132561206817627,
            "end_logit": -0.6534711718559265,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Utx proteins",
            "probability": 0.008246347089943646,
            "start_logit": 2.7733705043792725,
            "end_logit": -0.6534711718559265,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Runx2/p57 P1 promoter is accompanied by the simultaneous interaction of Wdr5 and Utx proteins",
            "probability": 0.006034524501980186,
            "start_logit": 2.461097240447998,
            "end_logit": -0.6534711718559265,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Mll2/COMPASS-\u00a0and",
            "probability": 0.0017451382888912016,
            "start_logit": 0.9158731698989868,
            "end_logit": -0.3489103615283966,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Utx proteins, both are components of COMPASS complexes.We also determined the presence of additional components of COMPASS complexes at the Runx2",
            "probability": 0.0013969338718478,
            "start_logit": 2.7733705043792725,
            "end_logit": -2.428961753845215,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Wdr5 and Utx proteins, both are components of COMPASS complexes",
            "probability": 0.0011624776947863086,
            "start_logit": 3.2132561206817627,
            "end_logit": -3.0525734424591064,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Mll2/COMPASS-\u00a0and Mll3/COMPASS-like",
            "probability": 0.0011287452215156281,
            "start_logit": 0.9158731698989868,
            "end_logit": -0.7846375703811646,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Mll3",
            "probability": 0.0010061714437192481,
            "start_logit": 0.8009190559387207,
            "end_logit": -0.7846375703811646,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Utx proteins, both are components of COMPASS complexes",
            "probability": 0.0007487636155919803,
            "start_logit": 2.7733705043792725,
            "end_logit": -3.0525734424591064,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Mll3/COMPASS-like complexes bind to the P1 promoter in osteoblastic cells expressing Runx2",
            "probability": 0.00022044150520960572,
            "start_logit": 0.8009190559387207,
            "end_logit": -2.302912950515747,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Runx2/p57 promoter, evidencing that the Mll2/COMPASS-\u00a0and",
            "probability": 6.589842128993764e-05,
            "start_logit": -2.3606014251708984,
            "end_logit": -0.3489103615283966,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Runx2/p57 promoter, evidencing that the Mll2/COMPASS-\u00a0and Mll3/COMPASS-like",
            "probability": 4.262271283022554e-05,
            "start_logit": -2.3606014251708984,
            "end_logit": -0.7846375703811646,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Mll",
            "probability": 7.805174502781957e-06,
            "start_logit": -1.298657774925232,
            "end_logit": -3.5441815853118896,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Mll-COMPASS complexes",
            "probability": 7.1811317467680746e-06,
            "start_logit": -1.298657774925232,
            "end_logit": -3.627511501312256,
            "question_text": "List the components of the COMPASS complex"
        }
    ],
    "5e6e5d1d51b80c9423000003": [
        {
            "text": "schizophrenia",
            "probability": 0.9762797050681404,
            "start_logit": 3.8806118965148926,
            "end_logit": 3.8250601291656494,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "schizophrenia.",
            "probability": 0.004185633848893647,
            "start_logit": 3.8806118965148926,
            "end_logit": -1.627030849456787,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "Genome-wide association studies (GWAS) have identified several significant loci associated with schizophrenia",
            "probability": 0.004171792503802966,
            "start_logit": -1.574791431427002,
            "end_logit": 3.8250601291656494,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "studies (GWAS) have identified several significant loci associated with schizophrenia",
            "probability": 0.0025912909482033947,
            "start_logit": -2.050981044769287,
            "end_logit": 3.8250601291656494,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "(GWAS) have identified several significant loci associated with schizophrenia",
            "probability": 0.0022498769729689338,
            "start_logit": -2.1922616958618164,
            "end_logit": 3.8250601291656494,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "zophrenia",
            "probability": 0.0019327691878718851,
            "start_logit": -2.3441834449768066,
            "end_logit": 3.8250601291656494,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "schi",
            "probability": 0.0015434032541966456,
            "start_logit": 3.8806118965148926,
            "end_logit": -2.624699115753174,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "association studies (GWAS) have identified several significant loci associated with schizophrenia",
            "probability": 0.0012729914537670593,
            "start_logit": -2.761767625808716,
            "end_logit": 3.8250601291656494,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "chizophrenia",
            "probability": 0.0011055138035001657,
            "start_logit": -2.902827024459839,
            "end_logit": 3.8250601291656494,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "GWAS) have identified several significant loci associated with schizophrenia",
            "probability": 0.0009323355311794634,
            "start_logit": -3.07319974899292,
            "end_logit": 3.8250601291656494,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "s",
            "probability": 0.0006018669209366376,
            "start_logit": 3.8806118965148926,
            "end_logit": -3.5664079189300537,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "several significant loci associated with schizophrenia",
            "probability": 0.0004909188478535457,
            "start_logit": -3.714613676071167,
            "end_logit": 3.8250601291656494,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "significant loci associated with schizophrenia",
            "probability": 0.00048752058223289825,
            "start_logit": -3.721560001373291,
            "end_logit": 3.8250601291656494,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "schizophrenia.Pathway enrichment analysis",
            "probability": 0.00045885428857989134,
            "start_logit": 3.8806118965148926,
            "end_logit": -3.8377115726470947,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": ") have identified several significant loci associated with schizophrenia",
            "probability": 0.0004465323013528219,
            "start_logit": -3.8093807697296143,
            "end_logit": 3.8250601291656494,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "associated with schizophrenia",
            "probability": 0.0003767698224401742,
            "start_logit": -3.9792580604553223,
            "end_logit": 3.8250601291656494,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "identified several significant loci associated with schizophrenia",
            "probability": 0.00029004424468067653,
            "start_logit": -4.240859031677246,
            "end_logit": 3.8250601291656494,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "wide association studies (GWAS) have identified several significant loci associated with schizophrenia",
            "probability": 0.00028472698305886203,
            "start_logit": -4.259361743927002,
            "end_logit": 3.8250601291656494,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "with schizophrenia",
            "probability": 0.0002795675827014869,
            "start_logit": -4.277648448944092,
            "end_logit": 3.8250601291656494,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "Genome-wide association studies (GWAS) have identified several significant loci associated with schizophrenia.",
            "probability": 1.7885853637876988e-05,
            "start_logit": -1.574791431427002,
            "end_logit": -1.627030849456787,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        }
    ],
    "5e44baaa48dab47f2600001a": [
        {
            "text": "PI3K/AKT",
            "probability": 0.1254231168830719,
            "start_logit": 5.849929332733154,
            "end_logit": 5.631759166717529,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "AKT",
            "probability": 0.09529174641012018,
            "start_logit": 5.575179576873779,
            "end_logit": 5.631759166717529,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "MAPK and PI3K/AKT",
            "probability": 0.08649751571702256,
            "start_logit": 5.478352069854736,
            "end_logit": 5.631759166717529,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "RAS/RAF/MEK/MAPK and PI3K/AKT",
            "probability": 0.08242708896932706,
            "start_logit": 5.430150508880615,
            "end_logit": 5.631759166717529,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "MAPK",
            "probability": 0.059656310949625854,
            "start_logit": 5.478352069854736,
            "end_logit": 5.2602434158325195,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "RAS/RAF/MEK/MAPK",
            "probability": 0.056848985886642465,
            "start_logit": 5.430150508880615,
            "end_logit": 5.2602434158325195,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "MEK/MAPK and PI3K/AKT",
            "probability": 0.05578365029877286,
            "start_logit": 5.039717197418213,
            "end_logit": 5.631759166717529,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "RAF/MEK/MAPK and PI3K/AKT",
            "probability": 0.049567380740106935,
            "start_logit": 4.921569347381592,
            "end_logit": 5.631759166717529,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "PI3K",
            "probability": 0.04707084638438294,
            "start_logit": 5.849929332733154,
            "end_logit": 4.65172004699707,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "RAS",
            "probability": 0.04045643086739291,
            "start_logit": 5.430150508880615,
            "end_logit": 4.920070648193359,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "MEK/MAPK",
            "probability": 0.038473322158937666,
            "start_logit": 5.039717197418213,
            "end_logit": 5.2602434158325195,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "RAS/RAF/MEK",
            "probability": 0.0381726826240579,
            "start_logit": 5.430150508880615,
            "end_logit": 4.861965179443359,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "RAS/RAF",
            "probability": 0.03560982583127707,
            "start_logit": 5.430150508880615,
            "end_logit": 4.792466640472412,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "RAF/MEK/MAPK",
            "probability": 0.03418603475346266,
            "start_logit": 4.921569347381592,
            "end_logit": 5.2602434158325195,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "MAPK and PI3K",
            "probability": 0.032462207734340255,
            "start_logit": 5.478352069854736,
            "end_logit": 4.65172004699707,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "RAS/RAF/MEK/MAPK and PI3K",
            "probability": 0.030934591159970798,
            "start_logit": 5.430150508880615,
            "end_logit": 4.65172004699707,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "MEK",
            "probability": 0.025833880646432755,
            "start_logit": 5.039717197418213,
            "end_logit": 4.861965179443359,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "RAF/MEK",
            "probability": 0.022955073594823204,
            "start_logit": 4.921569347381592,
            "end_logit": 4.861965179443359,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "RAF",
            "probability": 0.021413904301832536,
            "start_logit": 4.921569347381592,
            "end_logit": 4.792466640472412,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "MEK/MAPK and PI3K",
            "probability": 0.02093540408839953,
            "start_logit": 5.039717197418213,
            "end_logit": 4.65172004699707,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        }
    ],
    "5e35c75d158f994d3a000001": [
        {
            "text": "treat-to-target",
            "probability": 0.23763214699984156,
            "start_logit": -2.9561963081359863,
            "end_logit": -4.114781856536865,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "treat-to-target strategy",
            "probability": 0.1345494156297299,
            "start_logit": -2.9561963081359863,
            "end_logit": -4.683574199676514,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "treat",
            "probability": 0.10809271906136646,
            "start_logit": -2.9561963081359863,
            "end_logit": -4.9025163650512695,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "treat-to-target strategy in axSpA.",
            "probability": 0.10207807026186252,
            "start_logit": -2.9561963081359863,
            "end_logit": -4.959767818450928,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "Treat to target",
            "probability": 0.08378067735505844,
            "start_logit": -3.9982104301452637,
            "end_logit": -4.115289211273193,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "treat-to-target strategy in axSpA. Potential targets of treatment, association of targets with outcomes,",
            "probability": 0.051995012705096516,
            "start_logit": -2.9561963081359863,
            "end_logit": -5.634357929229736,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "treat-to-target strategy in axSpA. Potential targets of treatment,",
            "probability": 0.050959538347530677,
            "start_logit": -2.9561963081359863,
            "end_logit": -5.654473781585693,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "controversial. This review focuses on background for a treat-to-target",
            "probability": 0.03661305927432464,
            "start_logit": -4.826515197753906,
            "end_logit": -4.114781856536865,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "controversial",
            "probability": 0.022689683353788723,
            "start_logit": -4.826515197753906,
            "end_logit": -4.593276500701904,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "controversial. This review focuses on background for a treat-to-target strategy",
            "probability": 0.020730636792926544,
            "start_logit": -4.826515197753906,
            "end_logit": -4.683574199676514,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "Treat",
            "probability": 0.018489406611350817,
            "start_logit": -3.9982104301452637,
            "end_logit": -5.626293659210205,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "review focuses on background for a treat-to-target",
            "probability": 0.017618435876019037,
            "start_logit": -5.557974338531494,
            "end_logit": -4.114781856536865,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "controversial. This review focuses on background for a treat",
            "probability": 0.016654333936221892,
            "start_logit": -4.826515197753906,
            "end_logit": -4.9025163650512695,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "controversial. This review focuses on background for a treat-to-target strategy in axSpA.",
            "probability": 0.015727629802161153,
            "start_logit": -4.826515197753906,
            "end_logit": -4.959767818450928,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "focuses on background for a treat-to-target",
            "probability": 0.015054433826521121,
            "start_logit": -5.715247631072998,
            "end_logit": -4.114781856536865,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "This review focuses on background for a treat-to-target",
            "probability": 0.014331495840507972,
            "start_logit": -5.764460563659668,
            "end_logit": -4.114781856536865,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "Treat-to-target",
            "probability": 0.014261416382964912,
            "start_logit": -4.642613887786865,
            "end_logit": -5.241530418395996,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "background for a treat-to-target",
            "probability": 0.013505058356934226,
            "start_logit": -5.823855876922607,
            "end_logit": -4.114781856536865,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "ideal methods to reach this target remain controversial. This review focuses on background for a treat-to-target",
            "probability": 0.012694428746546032,
            "start_logit": -5.885756969451904,
            "end_logit": -4.114781856536865,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "controversial. This review",
            "probability": 0.012542400839246565,
            "start_logit": -4.826515197753906,
            "end_logit": -5.186071872711182,
            "question_text": "List targeted genome editing methodologies"
        }
    ],
    "5e3e8b1c48dab47f26000008": [
        {
            "text": "promoted the phosphorylation and dimerization",
            "probability": 0.26995128834705323,
            "start_logit": -0.6132773160934448,
            "end_logit": -0.400290310382843,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "dimerization",
            "probability": 0.14988196426276104,
            "start_logit": -1.20167076587677,
            "end_logit": -0.400290310382843,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "oligomerization",
            "probability": 0.1395514725249468,
            "start_logit": -1.5923429727554321,
            "end_logit": -0.08103267103433609,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "Phosphorylation and oligomerization",
            "probability": 0.08524709181316169,
            "start_logit": -2.0852224826812744,
            "end_logit": -0.08103267103433609,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "oligomerization of \u03b1-synuclein associated with GSK-3\u03b2 activation",
            "probability": 0.06826017624327121,
            "start_logit": -1.5923429727554321,
            "end_logit": -0.796139657497406,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "activation",
            "probability": 0.05774358346603111,
            "start_logit": -1.7596572637557983,
            "end_logit": -0.796139657497406,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "Phosphorylation and oligomerization of \u03b1-synuclein associated with GSK-3\u03b2 activation",
            "probability": 0.041697743535830584,
            "start_logit": -2.0852224826812744,
            "end_logit": -0.796139657497406,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "promoted",
            "probability": 0.03534175643409884,
            "start_logit": -0.6132773160934448,
            "end_logit": -2.433466672897339,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "phosphorylation and dimerization",
            "probability": 0.031527670471797914,
            "start_logit": -2.523209810256958,
            "end_logit": -0.6377337574958801,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "activating GSK-3\u03b2",
            "probability": 0.027604471692594026,
            "start_logit": -0.20713499188423157,
            "end_logit": -3.0866963863372803,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "promoted the phosphorylation and dimerization of endogenous \u03b1Syn by activating GSK-3\u03b2",
            "probability": 0.018390522552318874,
            "start_logit": -0.6132773160934448,
            "end_logit": -3.0866963863372803,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "promoted the phosphorylation",
            "probability": 0.0171407750330079,
            "start_logit": -0.9997804164886475,
            "end_logit": -2.770568609237671,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "Phosphorylation",
            "probability": 0.011644499077981738,
            "start_logit": -2.0852224826812744,
            "end_logit": -2.0717527866363525,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "promoted the phosphorylation and dimerization of endogenous \u03b1Syn",
            "probability": 0.010521651481424128,
            "start_logit": -0.9997804164886475,
            "end_logit": -3.2585935592651367,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "dimerization of endogenous \u03b1Syn by activating GSK-3\u03b2",
            "probability": 0.010210759358986578,
            "start_logit": -1.20167076587677,
            "end_logit": -3.0866963863372803,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "activating GSK-3\u03b2 in rTg4510 mice",
            "probability": 0.0057331277126466676,
            "start_logit": -0.20713499188423157,
            "end_logit": -4.658412933349609,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "lation and oligomerization",
            "probability": 0.005374724764697185,
            "start_logit": -4.849069118499756,
            "end_logit": -0.08103267103433609,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "activating GSK-3\u03b2 in rTg4510 mice.",
            "probability": 0.004803494660536022,
            "start_logit": -1.1460041999816895,
            "end_logit": -3.896461248397827,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "ization",
            "probability": 0.004699957768305058,
            "start_logit": -4.983222961425781,
            "end_logit": -0.08103267103433609,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "act",
            "probability": 0.004673268798549422,
            "start_logit": -0.20713499188423157,
            "end_logit": -4.8628153800964355,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        }
    ],
    "5e47546d3f54159529000019": [
        {
            "text": "ulcerative colitis",
            "probability": 0.872849023487752,
            "start_logit": 4.611429214477539,
            "end_logit": 4.521951675415039,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "colitis",
            "probability": 0.074026160823294,
            "start_logit": 2.144085168838501,
            "end_logit": 4.521951675415039,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "ulcerative colitis nonhuman primates. A limitation of currently used preclinical models of colitis",
            "probability": 0.04387442299899273,
            "start_logit": 3.2460765838623047,
            "end_logit": 2.8968732357025146,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "colitis nonhuman primates. A limitation of currently used preclinical models of colitis",
            "probability": 0.005301892702770642,
            "start_logit": 1.1328089237213135,
            "end_logit": 2.8968732357025146,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "ulcerative",
            "probability": 0.001899534215882418,
            "start_logit": 4.611429214477539,
            "end_logit": -1.6082022190093994,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "ulcerative co",
            "probability": 0.0007443687653398463,
            "start_logit": 4.611429214477539,
            "end_logit": -2.545029640197754,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "is",
            "probability": 0.0005528050658787639,
            "start_logit": -2.7530832290649414,
            "end_logit": 4.521951675415039,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "ul",
            "probability": 0.0002701421695476779,
            "start_logit": 4.611429214477539,
            "end_logit": -3.5586178302764893,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "colitis in the macaque. Furthermore, signs of colitis",
            "probability": 0.00010007320904789285,
            "start_logit": 0.1747036576271057,
            "end_logit": -0.1149386391043663,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "ulcerative colitis nonhuman primates. A limitation of currently used preclinical models of co",
            "probability": 8.111316746613708e-05,
            "start_logit": 3.2460765838623047,
            "end_logit": -3.3963682651519775,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "co",
            "probability": 6.312977439638217e-05,
            "start_logit": 2.144085168838501,
            "end_logit": -2.545029640197754,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "induced ulcerative colitis",
            "probability": 5.719055487088464e-05,
            "start_logit": -5.021699905395508,
            "end_logit": 4.521951675415039,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "colitis. Following subsequent DSS treatments, mild to moderate colitis",
            "probability": 3.98020789783941e-05,
            "start_logit": -0.24096298217773438,
            "end_logit": -0.6212548613548279,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "is nonhuman primates. A limitation of currently used preclinical models of colitis",
            "probability": 3.8012499126683026e-05,
            "start_logit": -3.8050951957702637,
            "end_logit": 2.8968732357025146,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "litis",
            "probability": 2.0206969994336175e-05,
            "start_logit": -4.6701273918151855,
            "end_logit": 3.1300179958343506,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "colitis. Following subsequent DSS treatments, mild to moderate colitis emerged with each DSS treatment and reduced signs of colitis",
            "probability": 1.9031579031025443e-05,
            "start_logit": -0.24096298217773438,
            "end_logit": -1.359074354171753,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "colitis during DSS treatment and further reduced signs of colitis",
            "probability": 1.8918047501262232e-05,
            "start_logit": -0.6867102384567261,
            "end_logit": -0.9193103909492493,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "litis nonhuman primates. A limitation of currently used preclinical models of colitis",
            "probability": 1.6004706479990575e-05,
            "start_logit": -4.6701273918151855,
            "end_logit": 2.8968732357025146,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "colitis emerged with each DSS treatment and reduced signs of colitis",
            "probability": 1.5545345764067166e-05,
            "start_logit": -0.44330134987831116,
            "end_logit": -1.359074354171753,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "colitis. Vedolizumab reduced signs of colitis during DSS treatment and further reduced signs of colitis",
            "probability": 1.2621837884817974e-05,
            "start_logit": -1.0913981199264526,
            "end_logit": -0.9193103909492493,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        }
    ],
    "5e80669e835f4e4777000025": [
        {
            "text": "angiotensin II receptor blockers",
            "probability": 0.6473670247575757,
            "start_logit": -1.5044578313827515,
            "end_logit": -2.962221384048462,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "ACE",
            "probability": 0.1090188920347849,
            "start_logit": -2.7330760955810547,
            "end_logit": -3.5149953365325928,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "an",
            "probability": 0.0633884634435939,
            "start_logit": -1.5044578313827515,
            "end_logit": -5.285852909088135,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers",
            "probability": 0.044289607133649225,
            "start_logit": -4.186621189117432,
            "end_logit": -2.962221384048462,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "COVID-19, and ACE",
            "probability": 0.03827532574834673,
            "start_logit": -3.779791831970215,
            "end_logit": -3.5149953365325928,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "ACE Inhibitor",
            "probability": 0.022718719489501916,
            "start_logit": -2.7330760955810547,
            "end_logit": -5.083327293395996,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "ACE2, COVID-19, and ACE",
            "probability": 0.013964721198516487,
            "start_logit": -4.788063049316406,
            "end_logit": -3.5149953365325928,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "COVID-19, and ACE Inhibitor",
            "probability": 0.00797629083194631,
            "start_logit": -3.779791831970215,
            "end_logit": -5.083327293395996,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "receptor blockers",
            "probability": 0.007790559911493319,
            "start_logit": -5.9244585037231445,
            "end_logit": -2.962221384048462,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "COVID-19",
            "probability": 0.006802300787888487,
            "start_logit": -3.779791831970215,
            "end_logit": -5.242539882659912,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "angiotensin-converting enzyme inhibitors",
            "probability": 0.00608096647335107,
            "start_logit": -4.186621189117432,
            "end_logit": -4.947807788848877,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "angiotensin II receptor blockers. Coronavirus binding to angiotensin-converting enzyme 2",
            "probability": 0.004796340509224306,
            "start_logit": -4.1539692878723145,
            "end_logit": -5.217770099639893,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "19, and ACE",
            "probability": 0.0047366101152548174,
            "start_logit": -5.8692755699157715,
            "end_logit": -3.5149953365325928,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "angiotensin-converting enzyme inhibitors and an",
            "probability": 0.004336720956359781,
            "start_logit": -4.186621189117432,
            "end_logit": -5.285852909088135,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "angiotensin-(1-7) pathway in children and the clinical evidence for how angiotensin-converting enzyme inhibitors",
            "probability": 0.004158863041686929,
            "start_logit": -4.566543102264404,
            "end_logit": -4.947807788848877,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "angiotensin-converting enzyme inhibitor",
            "probability": 0.003125258781183584,
            "start_logit": -4.186621189117432,
            "end_logit": -5.613454341888428,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "angiotensin-(1-7) pathway in children and the clinical evidence for how angiotensin-converting enzyme inhibitors and an",
            "probability": 0.0029659476970565805,
            "start_logit": -4.566543102264404,
            "end_logit": -5.285852909088135,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "ACE2, COVID-19, and ACE Inhibitor",
            "probability": 0.002910143166351095,
            "start_logit": -4.788063049316406,
            "end_logit": -5.083327293395996,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "ACE2",
            "probability": 0.0028154300603262794,
            "start_logit": -4.788063049316406,
            "end_logit": -5.116414546966553,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "ACE2, COVID-19",
            "probability": 0.0024818138619085396,
            "start_logit": -4.788063049316406,
            "end_logit": -5.242539882659912,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        }
    ],
    "5d387360a1e1595105000007": [
        {
            "text": "apoptosis",
            "probability": 0.19451460177349758,
            "start_logit": 5.603743076324463,
            "end_logit": 6.024683475494385,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "promote apoptosis",
            "probability": 0.1839763852498896,
            "start_logit": 5.548043251037598,
            "end_logit": 6.024683475494385,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "proliferation, migration and invasion, and promote apoptosis",
            "probability": 0.10245263847098623,
            "start_logit": 4.962636470794678,
            "end_logit": 6.024683475494385,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "inhibit liver cells proliferation, migration and invasion, and promote apoptosis",
            "probability": 0.08313504393733386,
            "start_logit": 4.753702163696289,
            "end_logit": 6.024683475494385,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "migration and invasion, and promote apoptosis",
            "probability": 0.06625866311318322,
            "start_logit": 4.526802062988281,
            "end_logit": 6.024683475494385,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "proliferation, migration and invasion",
            "probability": 0.06108666650416326,
            "start_logit": 4.962636470794678,
            "end_logit": 5.5075764656066895,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "inhibit liver cells proliferation, migration and invasion",
            "probability": 0.04956868636669661,
            "start_logit": 4.753702163696289,
            "end_logit": 5.5075764656066895,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "migration and invasion",
            "probability": 0.03950626276699503,
            "start_logit": 4.526802062988281,
            "end_logit": 5.5075764656066895,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "liver cells proliferation, migration and invasion, and promote apoptosis",
            "probability": 0.036575564876754604,
            "start_logit": 3.9326162338256836,
            "end_logit": 6.024683475494385,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "proliferation",
            "probability": 0.02770940805504329,
            "start_logit": 4.962636470794678,
            "end_logit": 4.717054843902588,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "invasion, and promote apoptosis",
            "probability": 0.023006760332689283,
            "start_logit": 3.4690239429473877,
            "end_logit": 6.024683475494385,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "inhibit liver cells proliferation",
            "probability": 0.0224847587188875,
            "start_logit": 4.753702163696289,
            "end_logit": 4.717054843902588,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "liver cells proliferation, migration and invasion",
            "probability": 0.02180792380920893,
            "start_logit": 3.9326162338256836,
            "end_logit": 5.5075764656066895,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "proliferation, migration",
            "probability": 0.01917912620347372,
            "start_logit": 4.962636470794678,
            "end_logit": 4.349105358123779,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "inhibit liver cells proliferation, migration",
            "probability": 0.015562873962069764,
            "start_logit": 4.753702163696289,
            "end_logit": 4.349105358123779,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "invasion",
            "probability": 0.013717619348399717,
            "start_logit": 3.4690239429473877,
            "end_logit": 5.5075764656066895,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "migration",
            "probability": 0.012403616743175095,
            "start_logit": 4.526802062988281,
            "end_logit": 4.349105358123779,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "liver cells proliferation",
            "probability": 0.009892251357691622,
            "start_logit": 3.9326162338256836,
            "end_logit": 4.717054843902588,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "apoptosis.",
            "probability": 0.008819480683469322,
            "start_logit": 5.603743076324463,
            "end_logit": 2.9311392307281494,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "promote apoptosis.",
            "probability": 0.008341667726391666,
            "start_logit": 5.548043251037598,
            "end_logit": 2.9311392307281494,
            "question_text": "What are the effects of CAMK4 inhibition?"
        }
    ],
    "5e4949d36d0a277941000006": [
        {
            "text": "ciliopathies",
            "probability": 0.2759866471094931,
            "start_logit": 1.3322722911834717,
            "end_logit": 0.9344837665557861,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "aggrecanopathies",
            "probability": 0.26557360954842185,
            "start_logit": 0.7047432065010071,
            "end_logit": 1.523552417755127,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "aggrecanopathies, channelopathies, ciliopathies",
            "probability": 0.147351869978047,
            "start_logit": 0.7047432065010071,
            "end_logit": 0.9344837665557861,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "aggrecanopathies, channelopathies",
            "probability": 0.07310200139462858,
            "start_logit": 0.7047432065010071,
            "end_logit": 0.23351611196994781,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "channelopathies, ciliopathies",
            "probability": 0.043656550383813345,
            "start_logit": -0.5117268562316895,
            "end_logit": 0.9344837665557861,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "ciliopathies, cohesinopathies, laminopathies",
            "probability": 0.04294122927073612,
            "start_logit": 1.3322722911834717,
            "end_logit": -0.9260362982749939,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "ciliopathies, cohesinopathies",
            "probability": 0.04246919445357223,
            "start_logit": 1.3322722911834717,
            "end_logit": -0.937089741230011,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "aggrecanopathies, channelopathies, ciliopathies, cohesinopathies, laminopathies",
            "probability": 0.022926726703878166,
            "start_logit": 0.7047432065010071,
            "end_logit": -0.9260362982749939,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "aggrecanopathies, channelopathies, ciliopathies, cohesinopathies",
            "probability": 0.02267470286963719,
            "start_logit": 0.7047432065010071,
            "end_logit": -0.937089741230011,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "channelopathies",
            "probability": 0.02165823350268754,
            "start_logit": -0.5117268562316895,
            "end_logit": 0.23351611196994781,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "ciliopathies, cohesinopathies, laminopathies, linkeropathies",
            "probability": 0.011584534871950955,
            "start_logit": 1.3322722911834717,
            "end_logit": -2.2361977100372314,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "ciliopathies, cohesinopathies, laminopathies, linkeropathies, lysosomal storage diseases",
            "probability": 0.007708744060746227,
            "start_logit": 1.3322722911834717,
            "end_logit": -2.6435134410858154,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "channelopathies, ciliopathies, cohesinopathies, laminopathies",
            "probability": 0.006792596521733275,
            "start_logit": -0.5117268562316895,
            "end_logit": -0.9260362982749939,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "channelopathies, ciliopathies, cohesinopathies",
            "probability": 0.006717928373856346,
            "start_logit": -0.5117268562316895,
            "end_logit": -0.937089741230011,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "ciliopathies,",
            "probability": 0.001966359135885639,
            "start_logit": 1.3322722911834717,
            "end_logit": -4.009685039520264,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "channelopathies, ciliopathies, cohesinopathies, laminopathies, linkeropathies",
            "probability": 0.0018324829683144968,
            "start_logit": -0.5117268562316895,
            "end_logit": -2.2361977100372314,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "ciliopathies, cohesinopathies,",
            "probability": 0.0015194077696342294,
            "start_logit": 1.3322722911834717,
            "end_logit": -4.267548084259033,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "ggrecanopathies",
            "probability": 0.0012914315725907313,
            "start_logit": -4.621397495269775,
            "end_logit": 1.523552417755127,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "cili",
            "probability": 0.0011797080215945712,
            "start_logit": 1.3322722911834717,
            "end_logit": -4.520601749420166,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "aggrecanopathies, channelopathies,",
            "probability": 0.00106604148877844,
            "start_logit": 0.7047432065010071,
            "end_logit": -3.99438738822937,
            "question_text": "List cohesinopathies"
        }
    ],
    "5e3c841148dab47f26000002": [
        {
            "text": "Alzheimer's disease",
            "probability": 0.9534043257245082,
            "start_logit": 4.0193023681640625,
            "end_logit": 4.023514270782471,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alzheimer's",
            "probability": 0.03640807976828251,
            "start_logit": 4.0193023681640625,
            "end_logit": 0.7582659125328064,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "heimer's disease",
            "probability": 0.007545193699596263,
            "start_logit": -0.8198259472846985,
            "end_logit": 4.023514270782471,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alzheimer",
            "probability": 0.001073928050881139,
            "start_logit": 4.0193023681640625,
            "end_logit": -2.7652018070220947,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "disease",
            "probability": 0.0007139222526869279,
            "start_logit": -3.177717924118042,
            "end_logit": 4.023514270782471,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "heimer's",
            "probability": 0.0002881317051643222,
            "start_logit": -0.8198259472846985,
            "end_logit": 0.7582659125328064,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Al",
            "probability": 0.00025372567887564347,
            "start_logit": 4.0193023681640625,
            "end_logit": -4.20802640914917,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "s disease",
            "probability": 0.00010398104863882617,
            "start_logit": -5.104283332824707,
            "end_logit": 4.023514270782471,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "zheimer's disease",
            "probability": 4.1863100833723284e-05,
            "start_logit": -6.014087200164795,
            "end_logit": 4.023514270782471,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alzheimer's disease is",
            "probability": 3.882361737908985e-05,
            "start_logit": 4.0193023681640625,
            "end_logit": -6.085251331329346,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alzheimer's disease is considered to be associated with the dyshomeostasis of metal ions such as aluminum, zinc, copper",
            "probability": 2.6331150201666886e-05,
            "start_logit": 4.0193023681640625,
            "end_logit": -6.473527431488037,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alz",
            "probability": 1.8240811571976192e-05,
            "start_logit": 4.0193023681640625,
            "end_logit": -6.84061861038208,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alzheimer's disease is considered to be associated with the dyshomeostasis of metal ions such as aluminum",
            "probability": 1.7088184147599113e-05,
            "start_logit": 4.0193023681640625,
            "end_logit": -6.905892848968506,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alzheimer's disease is considered to be associated with the dyshomeostasis of metal ions such as aluminum, zinc",
            "probability": 1.633378281969977e-05,
            "start_logit": 4.0193023681640625,
            "end_logit": -6.95104455947876,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alzheimer'",
            "probability": 1.5572648124517664e-05,
            "start_logit": 4.0193023681640625,
            "end_logit": -6.9987640380859375,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "'s disease",
            "probability": 1.1216568367391897e-05,
            "start_logit": -7.331099987030029,
            "end_logit": 4.023514270782471,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alzheimer's disease is considered",
            "probability": 9.17377941748553e-06,
            "start_logit": 4.0193023681640625,
            "end_logit": -7.527930736541748,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "heimer",
            "probability": 8.499012375647092e-06,
            "start_logit": -0.8198259472846985,
            "end_logit": -2.7652018070220947,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "s",
            "probability": 3.97077106856547e-06,
            "start_logit": -5.104283332824707,
            "end_logit": 0.7582659125328064,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "zheimer's",
            "probability": 1.5986450589508495e-06,
            "start_logit": -6.014087200164795,
            "end_logit": 0.7582659125328064,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        }
    ],
    "5e4703d13f54159529000016": [
        {
            "text": "chitosan-based long-circulating nanocarriers with radio-protective agents",
            "probability": 0.12804840836766795,
            "start_logit": -2.686164617538452,
            "end_logit": -2.525312662124634,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "effective radioprotection by chitosan-based long-circulating nanocarriers with radio-protective agents",
            "probability": 0.08644143618326333,
            "start_logit": -3.079105854034424,
            "end_logit": -2.525312662124634,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "chitosan-based long-circulating nanocarriers with radio-protective agents.",
            "probability": 0.08581519553009809,
            "start_logit": -2.686164617538452,
            "end_logit": -2.925524950027466,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "radio-protective agents",
            "probability": 0.07671863265840481,
            "start_logit": -3.1984283924102783,
            "end_logit": -2.525312662124634,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "chitosan-based long-circulating nanocarriers",
            "probability": 0.06369032587125992,
            "start_logit": -2.686164617538452,
            "end_logit": -3.2236883640289307,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "We demonstrate a strategy for effective radioprotection by chitosan-based long-circulating nanocarriers with radio-protective agents",
            "probability": 0.05854544039422797,
            "start_logit": -3.4687697887420654,
            "end_logit": -2.525312662124634,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "effective radioprotection by chitosan-based long-circulating nanocarriers with radio-protective agents.",
            "probability": 0.057931128098600175,
            "start_logit": -3.079105854034424,
            "end_logit": -2.925524950027466,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "radio-protective agents.",
            "probability": 0.05141512140845268,
            "start_logit": -3.1984283924102783,
            "end_logit": -2.925524950027466,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "effective radioprotection by chitosan-based long-circulating nanocarriers",
            "probability": 0.04299532738809026,
            "start_logit": -3.079105854034424,
            "end_logit": -3.2236883640289307,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "demonstrate a strategy for effective radioprotection by chitosan-based long-circulating nanocarriers with radio-protective agents",
            "probability": 0.04016593963734072,
            "start_logit": -3.8455536365509033,
            "end_logit": -2.525312662124634,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "We demonstrate a strategy for effective radioprotection by chitosan-based long-circulating nanocarriers with radio-protective agents.",
            "probability": 0.03923585211930639,
            "start_logit": -3.4687697887420654,
            "end_logit": -2.925524950027466,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "a strategy for effective radioprotection by chitosan-based long-circulating nanocarriers with radio-protective agents",
            "probability": 0.03833785759907419,
            "start_logit": -3.8921351432800293,
            "end_logit": -2.525312662124634,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "effective radioprotection",
            "probability": 0.035386829570906525,
            "start_logit": -3.079105854034424,
            "end_logit": -3.418440103530884,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "strategy for effective radioprotection by chitosan-based long-circulating nanocarriers with radio-protective agents",
            "probability": 0.034781000868095074,
            "start_logit": -3.989501714706421,
            "end_logit": -2.525312662124634,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "chitosan-based long-circulating nanocarriers. We demonstrate a strategy for effective radioprotection",
            "probability": 0.029639273426873763,
            "start_logit": -3.256345272064209,
            "end_logit": -3.418440103530884,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "We demonstrate a strategy for effective radioprotection by chitosan-based long-circulating nanocarriers",
            "probability": 0.029120066578869827,
            "start_logit": -3.4687697887420654,
            "end_logit": -3.2236883640289307,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "demonstrate a strategy for effective radioprotection by chitosan-based long-circulating nanocarriers with radio-protective agents.",
            "probability": 0.026918319466584132,
            "start_logit": -3.8455536365509033,
            "end_logit": -2.925524950027466,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "a strategy for effective radioprotection by chitosan-based long-circulating nanocarriers with radio-protective agents.",
            "probability": 0.025693179540530093,
            "start_logit": -3.8921351432800293,
            "end_logit": -2.925524950027466,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "long-circulating nanocarriers with radio-protective agents",
            "probability": 0.024607019604567744,
            "start_logit": -4.335541248321533,
            "end_logit": -2.525312662124634,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "effective",
            "probability": 0.024513645687786297,
            "start_logit": -3.079105854034424,
            "end_logit": -3.7855498790740967,
            "question_text": "List radioprotection agents."
        }
    ],
    "5e52c5166d0a27794100004d": [
        {
            "text": "early stages",
            "probability": 0.32144300102841034,
            "start_logit": -0.7369751334190369,
            "end_logit": -0.7726561427116394,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "early stages of multiple sclerosis have subtle balance problems that may affect gait stability",
            "probability": 0.09785723462004683,
            "start_logit": -0.7369751334190369,
            "end_logit": -1.9619667530059814,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "early stages of multiple sclerosis have subtle balance",
            "probability": 0.08379004052753602,
            "start_logit": -0.7369751334190369,
            "end_logit": -2.1171622276306152,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "early",
            "probability": 0.07446250898032473,
            "start_logit": -0.7369751334190369,
            "end_logit": -2.235180616378784,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "early stages of multiple sclerosis have subtle balance problems",
            "probability": 0.06272330642546538,
            "start_logit": -0.7369751334190369,
            "end_logit": -2.406743288040161,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "early stages of multiple sclerosis",
            "probability": 0.04817751490859984,
            "start_logit": -0.7369751334190369,
            "end_logit": -2.670583963394165,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "Gait stability at early stages of multiple sclerosis using different data sources.People at early stages",
            "probability": 0.03542154639296656,
            "start_logit": -2.9424750804901123,
            "end_logit": -0.7726561427116394,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "stages",
            "probability": 0.03397558233256013,
            "start_logit": -2.9841532707214355,
            "end_logit": -0.7726561427116394,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "early stages of multiple sclerosis have subtle balance problems that may affect gait stability.",
            "probability": 0.03301396132768278,
            "start_logit": -0.7369751334190369,
            "end_logit": -3.0485458374023438,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "using different data sources.People at early stages",
            "probability": 0.031126380182931523,
            "start_logit": -3.071739673614502,
            "end_logit": -0.7726561427116394,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "early stages of multiple sclerosis using different data sources.People at early stages",
            "probability": 0.028754928425059438,
            "start_logit": -3.1509861946105957,
            "end_logit": -0.7726561427116394,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": ".People at early stages",
            "probability": 0.025090996812355323,
            "start_logit": -3.2872862815856934,
            "end_logit": -0.7726561427116394,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "balance problems that may affect gait stability",
            "probability": 0.018182167241961686,
            "start_logit": -2.420043468475342,
            "end_logit": -1.9619667530059814,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "gait stability",
            "probability": 0.01815853969997457,
            "start_logit": -2.4213438034057617,
            "end_logit": -1.9619667530059814,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "Gait stability at early stages of multiple sclerosis using different data sources.",
            "probability": 0.016326893589050498,
            "start_logit": -2.9424750804901123,
            "end_logit": -1.5471627712249756,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "balance",
            "probability": 0.015568440453050671,
            "start_logit": -2.420043468475342,
            "end_logit": -2.1171622276306152,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "Gait stability",
            "probability": 0.01447239097345944,
            "start_logit": -2.9424750804901123,
            "end_logit": -1.6677336692810059,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "using different data sources.",
            "probability": 0.014347117752034755,
            "start_logit": -3.071739673614502,
            "end_logit": -1.5471627712249756,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "People at early stages",
            "probability": 0.013853406525296047,
            "start_logit": -3.8812642097473145,
            "end_logit": -0.7726561427116394,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "early stages of multiple sclerosis using different data sources.",
            "probability": 0.013254041801233454,
            "start_logit": -3.1509861946105957,
            "end_logit": -1.5471627712249756,
            "question_text": "List the stages/types of Multiple Sclerosis."
        }
    ],
    "5e6e8897c6a8763d23000003": [
        {
            "text": "AZD5991, S64315",
            "probability": 0.22335996503204184,
            "start_logit": 4.222743511199951,
            "end_logit": 4.680756092071533,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "AZD5991",
            "probability": 0.15381156530355064,
            "start_logit": 4.222743511199951,
            "end_logit": 4.307699680328369,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "AMG 176",
            "probability": 0.14075114276348527,
            "start_logit": 4.50496244430542,
            "end_logit": 3.9367458820343018,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "AMG 397",
            "probability": 0.11044918451904923,
            "start_logit": 4.5456223487854,
            "end_logit": 3.6536481380462646,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "AZD5991, S64315, AMG 176",
            "probability": 0.10614164259106426,
            "start_logit": 4.222743511199951,
            "end_logit": 3.9367458820343018,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "AMG 176, and AMG 397",
            "probability": 0.10604840513550752,
            "start_logit": 4.50496244430542,
            "end_logit": 3.6536481380462646,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "AZD5991, S64315, AMG 176, and AMG 397",
            "probability": 0.0799720108429953,
            "start_logit": 4.222743511199951,
            "end_logit": 3.6536481380462646,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "S64315",
            "probability": 0.03755161861732239,
            "start_logit": 2.4396753311157227,
            "end_logit": 4.680756092071533,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "S64315, AMG 176",
            "probability": 0.017844695137841784,
            "start_logit": 2.4396753311157227,
            "end_logit": 3.9367458820343018,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "S64315, AMG 176, and AMG 397",
            "probability": 0.013445016660912025,
            "start_logit": 2.4396753311157227,
            "end_logit": 3.6536481380462646,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "AMG",
            "probability": 0.0018247704054019632,
            "start_logit": 4.50496244430542,
            "end_logit": -0.4087933301925659,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "AZD5991, S64315,",
            "probability": 0.0017440095225271116,
            "start_logit": 4.222743511199951,
            "end_logit": -0.1718417853116989,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "AZD5991, S64315, AMG",
            "probability": 0.0013760749957560815,
            "start_logit": 4.222743511199951,
            "end_logit": -0.4087933301925659,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "AMG 176, and AMG",
            "probability": 0.0012494708249991668,
            "start_logit": 4.50496244430542,
            "end_logit": -0.7875273823738098,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "AZD5991, S64315, AMG 176, and AMG",
            "probability": 0.0009422366535089282,
            "start_logit": 4.222743511199951,
            "end_logit": -0.7875273823738098,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "AZD5991,",
            "probability": 0.0008952967788804769,
            "start_logit": 4.222743511199951,
            "end_logit": -0.8386285901069641,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "176",
            "probability": 0.0007662855575807097,
            "start_logit": -0.7082313299179077,
            "end_logit": 3.9367458820343018,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "AMG 176,",
            "probability": 0.0006681948621976101,
            "start_logit": 4.50496244430542,
            "end_logit": -1.41342294216156,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "venetoclax",
            "probability": 0.000581058900317705,
            "start_logit": 1.362650990486145,
            "end_logit": 1.5891607999801636,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "176, and AMG 397",
            "probability": 0.0005773548950601439,
            "start_logit": -0.7082313299179077,
            "end_logit": 3.6536481380462646,
            "question_text": "List Mcl-1 inhibitors."
        }
    ],
    "5e7659db835f4e4777000001": [
        {
            "text": "rotavirus vaccine",
            "probability": 0.3848370232278813,
            "start_logit": 1.3032724857330322,
            "end_logit": 0.41333791613578796,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "rotavirus vaccines",
            "probability": 0.2195700660699761,
            "start_logit": 1.3032724857330322,
            "end_logit": -0.14781062304973602,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "rotavirus",
            "probability": 0.14289493502082803,
            "start_logit": 1.3032724857330322,
            "end_logit": -0.5773723721504211,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "vaccine",
            "probability": 0.09077593039158897,
            "start_logit": -0.1411532759666443,
            "end_logit": 0.41333791613578796,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "vaccines",
            "probability": 0.05179251431285028,
            "start_logit": -0.1411532759666443,
            "end_logit": -0.14781062304973602,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "rotavirus vaccines over the last decade, rotavirus remains a leading cause of severe diarrheal disease among young children.",
            "probability": 0.0322680891283628,
            "start_logit": 1.3032724857330322,
            "end_logit": -2.0654032230377197,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "success of rotavirus vaccine",
            "probability": 0.012379316774355137,
            "start_logit": -2.1335203647613525,
            "end_logit": 0.41333791613578796,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "rotavirus vaccines over the last decade",
            "probability": 0.010187688696459283,
            "start_logit": 1.3032724857330322,
            "end_logit": -3.218302011489868,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "rotavirus vaccines over the last decade,",
            "probability": 0.009777630179092528,
            "start_logit": 1.3032724857330322,
            "end_logit": -3.259384870529175,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "vaccines over the last decade, rotavirus remains a leading cause of severe diarrheal disease among young children.",
            "probability": 0.007611444938475537,
            "start_logit": -0.1411532759666443,
            "end_logit": -2.0654032230377197,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "success of rotavirus vaccines",
            "probability": 0.00706306108296857,
            "start_logit": -2.1335203647613525,
            "end_logit": -0.14781062304973602,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "rus vaccine",
            "probability": 0.0054370386553313724,
            "start_logit": -2.956312894821167,
            "end_logit": 0.41333791613578796,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "rotavirus vaccines over the last decade, rotavirus",
            "probability": 0.005089844240758961,
            "start_logit": 1.3032724857330322,
            "end_logit": -3.9122347831726074,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "success of rotavirus",
            "probability": 0.004596599493563395,
            "start_logit": -2.1335203647613525,
            "end_logit": -0.5773723721504211,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "rot",
            "probability": 0.003613751908315671,
            "start_logit": 1.3032724857330322,
            "end_logit": -4.254735469818115,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "rus vaccines",
            "probability": 0.0031021208062645463,
            "start_logit": -2.956312894821167,
            "end_logit": -0.14781062304973602,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "vaccines over the last decade",
            "probability": 0.0024030871879324018,
            "start_logit": -0.1411532759666443,
            "end_logit": -3.218302011489868,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "vaccines over the last decade,",
            "probability": 0.002306361973926885,
            "start_logit": -0.1411532759666443,
            "end_logit": -3.259384870529175,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "Despite the success of rotavirus vaccine",
            "probability": 0.0022746535480264907,
            "start_logit": -3.8277196884155273,
            "end_logit": 0.41333791613578796,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "rus",
            "probability": 0.0020188423630416925,
            "start_logit": -2.956312894821167,
            "end_logit": -0.5773723721504211,
            "question_text": "Name two rotavirus vaccines."
        }
    ],
    "5e80e449835f4e477700002c": [
        {
            "text": "gallbladder",
            "probability": 0.15878642457237863,
            "start_logit": 5.064451694488525,
            "end_logit": 4.893700122833252,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "gallbladder, and testis",
            "probability": 0.1487950025917263,
            "start_logit": 5.064451694488525,
            "end_logit": 4.828709602355957,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "testis",
            "probability": 0.1450683684931835,
            "start_logit": 4.767175197601318,
            "end_logit": 5.100621700286865,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "small intestine, kidney, gallbladder",
            "probability": 0.1266820480165674,
            "start_logit": 4.838572025299072,
            "end_logit": 4.893700122833252,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "small intestine, kidney, gallbladder, and testis",
            "probability": 0.11871075070626216,
            "start_logit": 4.838572025299072,
            "end_logit": 4.828709602355957,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "small intestine",
            "probability": 0.103693782885033,
            "start_logit": 4.838572025299072,
            "end_logit": 4.693461894989014,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "kidney, gallbladder",
            "probability": 0.04720533099902615,
            "start_logit": 3.851398468017578,
            "end_logit": 4.893700122833252,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "kidney, gallbladder, and testis",
            "probability": 0.04423499910183898,
            "start_logit": 3.851398468017578,
            "end_logit": 4.828709602355957,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "small intestine, kidney",
            "probability": 0.034304801662217665,
            "start_logit": 4.838572025299072,
            "end_logit": 3.5873050689697266,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "kidney",
            "probability": 0.012782943934638214,
            "start_logit": 3.851398468017578,
            "end_logit": 3.5873050689697266,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "ovary",
            "probability": 0.009308782630718482,
            "start_logit": 3.7703912258148193,
            "end_logit": 3.351158857345581,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "testis,",
            "probability": 0.009083444068907967,
            "start_logit": 4.767175197601318,
            "end_logit": 2.3298699855804443,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "placenta and ovary",
            "probability": 0.00871641857576249,
            "start_logit": 3.704641342163086,
            "end_logit": 3.351158857345581,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "gallbladder, and testis,",
            "probability": 0.007922653674197337,
            "start_logit": 5.064451694488525,
            "end_logit": 1.8958662748336792,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "small intestine, kidney, gallbladder, and testis,",
            "probability": 0.006320804790939857,
            "start_logit": 4.838572025299072,
            "end_logit": 1.8958662748336792,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "placenta",
            "probability": 0.005158454509688086,
            "start_logit": 3.704641342163086,
            "end_logit": 2.826587438583374,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "the small intestine, kidney, gallbladder",
            "probability": 0.003866436524441879,
            "start_logit": 1.3492249250411987,
            "end_logit": 4.893700122833252,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "the small intestine, kidney, gallbladder, and testis",
            "probability": 0.003623146211802484,
            "start_logit": 1.3492249250411987,
            "end_logit": 4.828709602355957,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "the small intestine",
            "probability": 0.003164816450171416,
            "start_logit": 1.3492249250411987,
            "end_logit": 4.693461894989014,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "testis, while the abundance of which in brain-associated tissues",
            "probability": 0.002570589600498109,
            "start_logit": 4.767175197601318,
            "end_logit": 1.067551851272583,
            "question_text": "Which tissues express the ACE2 protein?"
        }
    ],
    "5e7768f9835f4e477700000b": [
        {
            "text": "Afrezza",
            "probability": 0.9911567381376607,
            "start_logit": 3.6441378593444824,
            "end_logit": 3.327510356903076,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "Afrezza inhalation insulin",
            "probability": 0.003631600273797532,
            "start_logit": 3.6441378593444824,
            "end_logit": -2.281688928604126,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "A",
            "probability": 0.0015525978416398485,
            "start_logit": 3.6441378593444824,
            "end_logit": -3.1314327716827393,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "frezza",
            "probability": 0.0013755825163544067,
            "start_logit": -2.9358575344085693,
            "end_logit": 3.327510356903076,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "Afrezza inhalation",
            "probability": 0.0010700597866133445,
            "start_logit": 3.6441378593444824,
            "end_logit": -3.503647804260254,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "za",
            "probability": 0.0007038528478908703,
            "start_logit": -3.6059207916259766,
            "end_logit": 3.327510356903076,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "Afrezza inhalation insulin.",
            "probability": 0.0003159585881502759,
            "start_logit": 3.6441378593444824,
            "end_logit": -4.723506450653076,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "compared with Afrezza",
            "probability": 0.0001294737190584211,
            "start_logit": -5.299012184143066,
            "end_logit": 3.327510356903076,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "intratracheal insufflation and compared with Afrezza",
            "probability": 4.681767299035344e-05,
            "start_logit": -6.316229343414307,
            "end_logit": 3.327510356903076,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "frezza inhalation insulin",
            "probability": 5.0401370951785145e-06,
            "start_logit": -2.9358575344085693,
            "end_logit": -2.281688928604126,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "za inhalation insulin",
            "probability": 2.5789182444710796e-06,
            "start_logit": -3.6059207916259766,
            "end_logit": -2.281688928604126,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "insulin",
            "probability": 2.4730653755110793e-06,
            "start_logit": -3.6478323936462402,
            "end_logit": -2.281688928604126,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "frezza inhalation",
            "probability": 1.4850885609525116e-06,
            "start_logit": -2.9358575344085693,
            "end_logit": -3.503647804260254,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "Ins_SD)",
            "probability": 1.0156496063751859e-06,
            "start_logit": -2.6713852882385254,
            "end_logit": -4.14806604385376,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "Ins_SD",
            "probability": 9.51994944648717e-07,
            "start_logit": -2.6713852882385254,
            "end_logit": -4.212790012359619,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "DPI product",
            "probability": 8.483492884734224e-07,
            "start_logit": -3.7093069553375244,
            "end_logit": -3.290135622024536,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "insulin spray-dried powder for DPI product",
            "probability": 7.801916364086185e-07,
            "start_logit": -3.793059825897217,
            "end_logit": -3.290135622024536,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "za inhalation",
            "probability": 7.598844857135939e-07,
            "start_logit": -3.6059207916259766,
            "end_logit": -3.503647804260254,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "inhalation insulin",
            "probability": 7.25183484737989e-07,
            "start_logit": -4.874621391296387,
            "end_logit": -2.281688928604126,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "Ins",
            "probability": 6.601531219200587e-07,
            "start_logit": -2.6713852882385254,
            "end_logit": -4.578877925872803,
            "question_text": "Name two inhalable insulin products."
        }
    ]
}
